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ABSTRACT OF DISSERTATION 
 
 
DESIGNING MOLECULAR RECOGNITION IN THE CONTEXT OF  
HYDROGEN BONDING AND MOLECULAR DYNAMICS 
 
The effect of hydrogen bonding on the conformation of organic molecules 
unifies two projects in this thesis. In one project, the stability of the intramolecular 
hydrogen bond in derivatives of 2-guanidinobenzimidazole was studied by 
dynamic 1H NMR spectrometry. The impact that this intramolecular hydrogen 
bond had on the bond order of the neutral guanidino group and on the dynamic 
conformation of these aromatic structures was related to the concept of hydrogen 
bond-assisted resonance. In another project, an oligomer possessing repetitive 
conformation and capable of much inter- and intramolecular hydrogen bonding 
was designed and synthesized. The sensitivity of this oligomer to changes in 
anion concentration, as well as its own propensity to self-aggregate were 
measured.  
Hydrogen bonds found in many biological oligomers are connected though 
a system of conjugated bonds.  Guanidinobenzimidazole is a conjugated system 
of carbon and nitrogen, connected by an intramolecular hydrogen bond.  Several 
derivatives of guanidinobenzimidazole were synthesized, and the effect of 
several simple alkyl for hydrogen substitutions were studied.  
Guanidinobenzimidazole was used as a model to study what effect the 
conjugation and the intramolecular hydrogen bond have on each other.   
The formation of redundant low energy hydrogen bonds is universal in 
biological oligomers.  In DNA and RNA multiple hydrogen bonds are formed with 
a typical energy contribution of only 1-2 kcal/mol.  Individually, these interactions 
do not give the biological oligomers their conformational stability, but together 
they are very stable. The urea and amide based oligomers designed in the work 
and discussed in the thesis should form multiple hydrogen bonds with 
themselves and/or with anionic guests. Chiral oligoureas were designed to 
possess this characteristic of cooperative conformation that so many biological 
oligomers and polymers share.  
KEYWORDS: Intramolecular hydrogen bond, Conformational design, 
Benzimidazole, Oligomers 
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Chapter 1  
A model system for intramolecular hydrogen bonds 
connected through a conjugated heteroatom system 
1.1 Overview 
The theme of this thesis is the exploration of hydrogen bonds as a 
controlling factor in the conformation of organic molecules. In most biological 
systems, including protein and DNA, hydrogen bonds help to form the complex 
biological structures necessary to sustain life. Regarding hydrogen bonding in 
protein and DNA, other factors including steric control lead to complex 
substructures including the α-helix, β-sheet and in DNA, the double helix. An 
understanding of the mechanisms and patterns involved in hydrogen bonding is 
crucial to the ability to understand and modify the activity of these biological 
structures. 
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Figure 1.1 1,5-Diaminoaromatic structures 
In the first part of the thesis, the reader will encounter a detailed analysis 
of the energetic contribution to overall conformational stability of six-centered 
intramolecular hydrogen bonds in nitrogen-based aromatic systems, which can 
have more than one tautomeric form. In this type of system the rate of hydrogen 
atom exchange is important because hydrogen atom exchange converts one 
tautomer to another. Furthermore, the hydrogen atom exchange tautomers 
possess different bond orders. A double bond greatly impedes bond rotation 
whereas a single bond allows bond rotation. 
In chapter two there is a discussion on the details of syntheses of 2-
aminobenzimidazole derivatives. These syntheses uses 2-aminobenzimidazole 
and 1,2-phenylenediamine with electrophiles including carbodiimides and dialkyl-
dicyandiamides (N,N-dialkyl-dicyandiamides). The synthesis of these compounds 
was facile and included only one or two synthetic steps to get from a commercial 
3 
product to the desired chemical. In most cases only required crystallization for 
purification. For 1g an initial purification was done, by column and a subsequent 
crystallization was required due to the tendency of these compounds to streak on 
the column. 
In Chapter three this thesis moves from a problem in minute analysis to a 
problem in the global design of a family of oligomers (oligoureas) that can take 
on hydrogen bond-dependent conformations. The effort was directed toward the 
mimicry of the peptide backbone in its ability to bind anionic guests as in the case 
of sulfate6,29 and phosphate binding proteins. Since it is the N-H contacts in the 
phosphate binding protein that stabilize the enfolded anions,26 we reasoned that 
oligoureas should do this better. Oligoureas have twice as many N-H hydrogen 
bond donors per residue than the peptide chain. The work in this thesis scratches 
the surface of the full potential of this project to flower into a comprehensive 
study. Forays were made into the synthesis of the desired materials. Using the 
conformation and intermolecular hydrogen bonding in a crystal structure of a 
dimer as a footstool, we extrapolated to the conformation of extended structures 
using molecular modeling. Some physical studies (nuclear magnetic resonance 
spectrometry and circular dichroism spectrometry) were also performed to assay 
the hydrogen bonding interactions between oxo-anions and oligoureas. 
Before we began this work there was discrepancy in the literature 
regarding the presence of an intramolecular hydrogen bond in 
guanidinobenzimidazole. In our studies we found indirect evidence for the 
existence of a weak, intramolecular hydrogen bond in guanidinobenzimidazole 
4 
through a study of derivatives for this molecule. Because this hydrogen bond is 
weak hydrogen atom exchange is an important phenomena in the control of the 
rate of hydrogen bond cleavage. The relative rates of exchange processes in 
guanidinobenzimidazole is therefore very solvent dependent. 
In the other theme of this thesis, interactions between de novo oligomers 
and anions were studied by modeling and a few binding assays of various 
derivatives to determine the influence of the shape and conformation of the 
monomer units on the shape and resulting properties of the oligomer. The effect 
of intramolecular hydrogen bonds and aggregation were studied for their ability to 
lead to interesting conformations of oligoureas. The oligomers contained 
hydrogen bond donors and acceptors, as well as a significant volume of 
hydrophobic matter. We hope that aggregation and self-condensation of the 
monomer units will lead to cooperative effects in these large oligomers, leading 
to stronger hydrogen bond interactions and stable repeating conformations. 
1.2 Introduction 
Guanidinobenzimidazoles 1a-c, g  and 2-amino-1-
carboxamidinylbenzimidazole 1d-f  offer a unique opportunity to study the effect 
of substitution patterns on the strength of an intramolecular hydrogen bond. The 
hydrogen bonds of these structures were analyzed to determine the 
conformational control that they exert over conjugated systems capable of 
tautomerization. The intramolecular hydrogen bonds in these structures are 
found in a general class of 1,3-diamino aromatic structures. A classic example of 
this type of hydrogen bond is found in ‘proton sponge’, 2, in its protonated 
5 
form.9,20,21 Crystal structures of protonated 1,8-diaminonaphthalene derivatives 
have an N-H-N hydrogen bond length of ~2.65 Å.9 This value is close to the N-H-
N bond distance in neutral guanidinobenzimidazole in the solid state (crown ether 
complex 2.69 Å8, and uncomplexed 2.75 Å35). Isopropyl substituted 
guanidinobenzimidazole, 1c and 1g also had similar bond distances of 2.67 Å, 
and 2.78 Å (this work). The gas state calculated structure of 1f had a N-H-N bond 
distance of 2.80 Å despite some steric issues that prevent a planar molecule. In 
the crystal structure of 1d there were no intramolecular hydrogen bonds, 
indicating that the hydrogen bond should be weak.  
The 1,8-diaminonaphthalene salts have raised questions about the 
possibility of low barrier hydrogen bonding. The major difference between these 
six-centered internal hydrogen bond acceptor pairs and the models studied in 
this work are the charge and the symmetry of the intramolecular hydrogen bond. 
Protonation of 2 reduces the strain caused by the steric crowding and the 
repulsion between the lone pairs of the nitrogen atoms, and lowers the energy 
required for protonation. The proton involved in the hydrogen bond in 2 is 
constrained to point at the hydrogen bond-acceptor nitrogen atom, strengthening 
the intramolecular hydrogen bond.34 
Conjugated systems can increase hydrogen bond strength. When a 
system, like 1, significantly perturbs the stability of an intramolecular hydrogen 
bond, the effect is referred to as resonance-assisted hydrogen 
bonding.16,17,36,37 Our work indicated that the stability of the intramolecular 
hydrogen bond in model structures 1a-f was intimately tied to the local structure. 
6 
This work compared the stability of the hydrogen bond in 1b-c,g  with analogous 
interactions in 1d-f . The solvent effect was also considered. The hydrogen bond 
in 1a-c,g  had limited control of the dynamics of the structure, but slow proton 
exchange, and limited conformational mobility were required to explain how the 
hydrogen bond in 1d-f  appeared to contribute significantly to the dynamics of the 
structure. 
1.2.1 The impact of hydrogen bonds on the conformation of organic 
molecules 
Intramolecular hydrogen bonds are implicated in the control of the 
conformation of many biological molecules and are said to contribute to the 
interactions necessary for efficient molecular recognition.11,12,25,32 Hydrogen 
bonds are a primary source of conformational stability in proteins and DNA, 
GHFUHDVLQJWKHPRELOLW\RIKHOLFHV-VKHHWVDQG-turns. In DNA, the double 
helix is held together by multiple hydrogen bonds in a conjugated system. In 
these systems, each hydrogen bond has an estimated strength of 6-7 kcal/mol 
from mass spectrometric experiments.18 All together, these interactions bind the 
strands together, and provide a basis for the genetic code. However, each 
hydrogen bond individually is weak enough for the changes in state necessary 
for the repair and packaging processes required by the biological mechanism. 
The strength of an isolated hydrogen bond interaction is generally 
between 2.1 and 5.8 kcal/mol,16 and is primarily an electrostatic interaction.  The 
length of this type of hydrogen bond is between 2.65 Å and 2.84 Å from 
heteroatom to heteroatom.15,16 X-ray diffraction analysis of derivatives of 2-
7 
aminobenzimidazole analyzed in this work uncovered hydrogen bonds in this 
range of N–H–N distances. This indicates that 1b,c,g  possess mid-range, text 
book hydrogen bonds that may say something in general about the impact of 
hydrogen bonds on conformational stability. These derivatives were compared to 
another derivative that displayed similar dynamics, but was stericly inhibited from 
forming short hydrogen bonds. Hydrogen bonds that are longer than 2.84 Å are 
usually considered weak, and those that are shorter than 2.65 Å are considered 
strong. The crystal structure of 1d indicated that 1d-f  might not necessarily have 
a strong hydrogen bond despite dynamics that indicate that exchange is slow 
between the two alkyl groups R3 and R4. 
One of the reasons to study six-centered intramolecular hydrogen bonds 
is their putative usefulness in stabilizing designed conformations of molecules for 
the purpose of molecular recognition and drug design. The conformation instead 
of just the structure is often the target in the design of pharmacophores. This 
requires the ability to direct the molecular conformation, a task in which hydrogen 
bonds should prove useful. In pursuit of this task, five- and six-centered 
intramolecular hydrogen bonds can be used to induce greater stability in 
dendrimers with the goal of developing dendrimers that fold into stable ordered 
conformations.23 Circular dichroism  (CD) shows that the 2-aminobenzamide 
connectors, highlighted in bold in the figure below, increased the structural 
stability of this dendrimer. Without these connectors, the degree of helicity in the 
dendron was highly solvent dependant.22,33 In addition, without the connector, 
changing to a polar solvent caused a decrease in the CD absorption of the 
8 
dendrimers. Addition of the connector in each generation of the dendrimer 
caused increased helical order with each new generation.23 This comes despite 
the fact that the chromophore is concentrated at the periphery of the dendron.  
NR
O
O
N
N
H
H O
O
N
N
H
O
O
N
N
H
H
O
H
N
O
NH
N
H
N
O
O N
N
H
H
O
NH
O
AcO AcO
S
N
H
OAc
OAc
S
OAc
OAc
S
AcO
AcO
S
 
Figure 1.2 Conformational control of dendron packing with five and six-
centered intramolecular hydrogen bonds in a second-generation dendron. 
The conformation of the above dendron is directed by intramolecular 
hydrogen bonds.22 If the internal structure of the dendron was stabilized in a 
helical form this would correlate to increased peripheral helicity. A 2-
aminobenzamide turn unit highlighted in bold in the figure above was used to link 
each generational shell, and formed a stable six-centered intramolecular 
hydrogen bond between adjacent amides linked through this subunit. The linker 
induces a turn in the dendron that folds the outer dendritic shells.22 The 
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conformational direction of the intramolecular hydrogen bond is assisted by the 
stiffness of the three bonds between the hydrogen bond donor and acceptor. 
This allows for a finite amount of conformers, and an enhancement of the 
conformational direction of the intramolecular hydrogen bond results.  
A similar result comes from 2; in it, the cleavage of the hydrogen bond is 
slow on the NMR time scale.20 This proton sponge is protonated and 
deprotonated slowly and equilibration of the (d,l)[2H+] to the thermodynamic 
mixture of meso and racemic forms takes about 10 min.9 The free energy barrier 
to rotation does not decrease with increasing solvent polarity, and the strain 
energy, which is relieved upon protonation of the tetramethyl proton sponge 
analogous to 2, has been calculated at 35 kJ/mol.9 From these observations, it 
appears that these six-centered intramolecular hydrogen bonds are useful for 
controlling conformation in structures in which conformational options are limited. 
1.2.2 The intramolecular hydrogen bond 
Measurement of the distance between heteroatoms is quite useful in 
identifying strong hydrogen bonds inside proteins and other intramolecular 
hydrogen bonds. The parameter, dAB is the distance between two electronegative 
atoms, A and B, in the species A—H---B. As dAB decreases, the A-H bond length 
increases. In 1,3-diketones at a dOO of 2.4 Å,32 the proton is equidistant from 
both oxygen atoms, and the O-H distance decreases in length as dOO increases 
(See Figure 1.3). The increased symmetry and decreased dOO reduces the 
barrier to hydrogen atom exchange between the two oxygen atoms to the point 
where the barrier can become less than the zero point vibrational energy.32  
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Figure 1.3 Normal hydrogen bonds versus the resonance assisted 
hydrogen bond showing a lowering of the energy barrier to proton 
exchange from resonance considerations. 
This type of hydrogen bond is called a ‘low barrier hydrogen bond’ and is 
sometimes identified by a distinctive change in the 1H NMR chemical shift of the 
protons of interest. The chemical shift of some of the NH protons in 1c and 1g 
moved downfield as the temperature of the sample was reduced. The large 
downfield chemical shift is not seen in 1d. This is the derivative with greater 
conformational control, but no apparent hydrogen bond in crystal structure 
evidence. 1c and 1g are the chemicals in which a short intramolecular hydrogen 
bond was found in the crystal structure. In 1d a short intramolecular hydrogen 
bond was not found in the crystal structure. This effect has been used to identify 
low barrier hydrogen bonds, but other evidence contradicts this conclusion. In 
one piece of evidence the downfield proton has a similar chemical shift at room 
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temperature as an imidazole proton, and this exists in the 1c, and 1g, not in 1d. 
In a low barrier hydrogen bond, the proton oscillates equally between the two 
heteroatoms, and as the temperature is reduced, the proton spends more time 
exactly between the two heteroatoms. This effect decreases the electronic 
shielding of the hydrogen nucleus, which results in a downfield shift.  
Intramolecular hydrogen bonds show a similar effect, but the magnitude is 
generally decreased compared to low-barrier hydrogen bonds. Thus, smaller 
downfield shifts are used to identify intramolecular hydrogen bonds.19 In one 
system, VT-NMR and VT-IR were used to detect and identify free and 
intramolecularly bound amide NH.19 The intramolecular hydrogen bond seen in 
1c, and 1g however had little effect upon the dynamics of the guanidine moiety 
under protic conditions. Under conditions with no protic solvent and limited 
amounts of an analyte, conformational control increased. 
1.2.3 Intramolecular resonance assisted hydrogen bonds 
Intramolecular hydrogen bonds connected by a series of conjugated 
bonds can be much stronger than the normal hydrogen bond with the same two 
atoms not electronically connected by a π-system. This hydrogen bond is 
typically called a ‘resonance assisted hydrogen bond.’ Hydrogen bonds can 
affect changes in covalent bond order. Figure 1.3 shows 4, which is a typical 
resonance assisted hydrogen bond. Compound 4 is connected by a series of 
conjugated bonds and when compared to 3, has the stronger hydrogen bond. 
The carbonyl in 4 is lengthened, and in fact, this trend is general. The smaller the 
O-O distance, the longer the carbonyl stretching frequency.15,16 
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In this part of the thesis we probe the differences in stability between two 
types of six-centered intramolecular hydrogen bonds both possessing π-
conjugated N1-C2-C3-C4-N5-H6 connectivity 1a-c,g  and 1d-f . We found that the 
relationship between the two different types of six-centered intramolecular 
hydrogen bonds was tentative and differences could not be directly compared.  In 
1a-c,g proton exchange obscured the energy of the intramolecular hydrogen 
bond, but evidence does suggest that the hydrogen bond and the hydrogen atom 
exchange that accompanies it is adds more electron density between C2 and 
N10 and less between C11 and N10. 
1.3 Determination of the conformational stability of a six-centered aromatic 
system with an intramolecular hydrogen bond. 
Six-centered aromatic structures with an intramolecular hydrogen bond 
have proven to be useful in the design of conformationally stable molecules. This 
functionality, seen in structure 1a-g, was investigated experimentally though an 
analysis of the dynamics of these molecules. The hydrogen bond in 1a should be 
stable in solution, but the chemical literature gives conflicting evidence regarding 
the stability of the intramolecular hydrogen bond of guanidinobenzimidazole. The 
crystal structures of 1a show an N1-N12 distance of 2.75 Å,35 and show the 
molecule to be planar.1 This implies that the hydrogen bond can obtain optimal 
conformation.16,17 However, in solution there is little evidence for a strong 
intramolecular hydrogen bond or for a static planar structure.1,7,35,38 Solution 
state 15N, 13C and 1H NMR studies indicate a weak or non-existent intramolecular 
hydrogen bond for 1a because the 15N12/ 15N13 exchange is rapid and 
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accelerated by protic solvents.1,5,10 The exchange of 15N1/ 15N3 in 1a at the 
imidazole ring correlates with protic exchange, but is not mechanistically related 
to guanidino 15N12/ 15N13 exchange. In 1a dissolved in CD3OD, both processes 
are fast on the NMR time scale; however, DMSOd6 suspends 
15N1/ 15N3 
exchange and allows 15N12/ 15N13 exchange. This behavior indicates that proton 
exchange is a bimolecular process in the absence of protic polar species. In 
DMSOd6 intermolecular proton exchange is suspended by impeding the 
aggregation of 1a. Our studies of the guanidinobenzimidazole derivatives also 
indicate that exchange of the benzo hydrogen atoms is more strongly related to 
proton exchange than exchange of the alkyl groups attached to the guanidine 
terminus. 
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Figure 1.4 Crystal structure of 1c 
 
Figure 1.5 crystal structure of 1g 
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Figure 1.6 Crystal structure of 1d 
Figures 1.4 and 1.5 show that the guanidinobenzimidazole derivatives 
1c,g  are planar in the solid state, while Figure 1.6 shows that 1d was not. The 
intermolecular hydrogen bonds in the crystal structure of 1c did not interfere with 
the planarity of the molecule as seemed to be the case in 1d Figure 1.6. 
Molecules of 1c stacked in antiparallel fashion hydrogen bonded with each other 
to form a T-shaped aggregate. This interaction could have been of the cation-π or 
proton-π type that have been recently investigated.14,28,31,40 
In contrast to the molecule 1c, in one molecule of 1d N3 and N10 
hydrogen bonded with a symmetry-unrelated molecule of 1d at N12 (16). In the 
crystal structure determination of 1d the dihedral angle of axis V (see Figure 1.7) 
was close to 90° with 4 different intramolecular hydrogen bonds with other 
Carbon 
Nitrogen 
Oxygen 
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molecules of 1d, and one with the carbonyl oxygen of a molecule of ethyl 
acetate. This occurs despite the fact that esters tend to be very poor hydrogen 
bond acceptors. In solution, the amount of tight intermolecular hydrogen bonds 
should have been reduced and the packing forces of the crystal eliminated. In 
fact, the two isopropyl methine protons were distinctly different in the proton 
spectra. This may be attributed to an intramolecular hydrogen bond, however in 
contrast to what is observed for the 1a-c,g , exchange rates were unaffected by 
the polarity and proton availability of the solvent. A gas phase calculation 
minimized to a dihedral angle of 36-42° for rotation about axis V for the TT 
conformer of 1d shown in Figure 1.9. This calculation was run with Gaussian at 
b3lyp/631G* theory level. The structure was optimized at this theory level using 
the standard minimization protocol for all possible conformers described in the 
text under Figure 1.10. 
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Figure 1.7  Axes of rotation observed to exchange protons in 1H NMR 
This work studied the impact of small changes in the substitution pattern 
of a conjugated heteroaromatic system and an intramolecular hydrogen bond in 
guanidinobenzimidazole on the structure and dynamics of the molecule. The 
barriers and rates were determined by monitoring the exchange of a set of alkyl 
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protons or a set of benzo protons on the derivative of 1. For derivatives 1b,c  the 
rate of exchange by rotation was determined for two bonds, N13-C11 and N10-
C2 (axis Y and Z in Figure 1.7) using VT-H1NMR for acquisition of kinetic data. 
For derivatives 1g, the rate of exchange by rotation was determined for two 
bonds, N10-C11 and N10-C2 (axis X and Z in Figure 1.7) using VT-H1NMR for 
acquisition of kinetic data. Exchange was assumed to occur around axis Y but 
the rates were too fast or the chemical shifts too similar for interpretation of the 
exchange rates. Exchange rates were also determined for the rotation around 
N13-C11 and N1-C11 (axis W, V in Figure 1.7) for 1d,e.  In 1a-c, rotation around 
axis X and Z broke the intramolecular hydrogen bond, but rotation around axis Y 
did not. Rotation around axis X was not favored because this rotation would have 
resulted in a sterically strained structure instead of a hydrogen-bonded structure. 
Only rotation around Y and Z were observed. In 1d,e rotation about axis U and V 
broke the hydrogen bond, and W did not. However, proton exchange was 
required for the exchange to occur. The molecule only registered one pKa at 
about pH 7 and none at a low pH. Proton exchange may be very slow at the 
carboxamidine nitrogen atoms in this situation. Again, two rotations were 
observed W and V. Rotation around the axis U by itself would  work against a 
double bond. To get to a ground state from this conformation would require 
another rotation around axis V. With a proton exchange, rotation U combined 
with V would be the same as a simple, single rotation around W. This issue is 
discussed in detail in the text under Figure 1.9. 
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The CN double bond in 1d,e appeared to direct the conformation of alkyl 
groups.  One alkyl group was held over the benzo part of the heterocycle, and 
the other near the amine. The hydrogen bond could not be strong due to the 
significant steric hindrance that prevented planarity in 1d.  With 1b,c  there were 
more degrees of rotational freedom for the six-centered intramolecular hydrogen 
bond than for 1d,e. The molecule 1b,c appeared to rotate about axis Z with 
almost no hindrance from the intramolecular hydrogen bond under protic 
conditions.  
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Table 1.1 Rate of exchange for the derivative at the indicated axis in the 
indicated solvent. 
              Solvent 
 
   Bond 
CD3OD CDCl3 
Conc. Of protic 
material in CDCl3 
sample per 750 ul 
1b Y 72.5 Hz (213 K) * 8 mg 1b 
1c Z 81.1 Hz (213 K) 
16.3(218 K) 
60.2 (243 K) 
* 
8 mg 1c 
8mg 1c 
20 mg 1c 
1c Y 962.8 Hz (225 K) 1332.9 Hz (228K) 20 mg 1c 
1c (N13FiPr) 967.5 Hz (214 K) * 20 mg 1c 
1d V 722 Hz (328 K) 406.2 Hz (305K) 8 mg 1d 
1d W 132.8 Hz (250 K) 100.0 Hz (257K) 8 mg 1d 
1e V 156.2 Hz (290 K) 123.1 Hz (296K) 8 mg 1e 
1e W 14.9 Hz (230 K) ND 8 mg 1e 
1g X 116 Hz (223 K) 283 (263 K) 8 mg 1g 
1g Z 158 Hz (223 K) 7 Hz (263 K) 8 mg 1g 
 
1.3.1 Determination of the energy barriers for guanidinobenzimidazole 
derivatives by VT- 1H-NMR. 
The above rates of exchange in table 1.1 were used to determine the 
barriers to exchange for all the derivatives of 2-aminobenzimidazole.  Exchange 
rates were determined from the equation k=ûAB/21/2 where ûAB is the difference 
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in chemical shift of the resonances undergoing chemical exchange. Limiting 
values for ûAB in many cases were determined by plotting the difference in 
chemical shift over a range of temperatures. Substituting the exchange rate, k, 
into the Eyring equation, k=(kBT/h)exp(-ûG‡/RT), allows for the determination of 
ûG‡. The error in the rate measurement was about 6-9% as given by gNMR™ for 
the accuracy of its full line shape analysis. The concentration of the analyte is 
given, because the rates are at least partly dependant upon proton availability. 
For cases in which the two peaks did not coalesce, and for double checks 
of the accuracy of the coalescence method, the rate of exchange was found by 
analyzing the shape of the peak with the program gNMR™. The program 
estimated the rate of exchange required to simulate a peak with the required 
peak width and position, from the low temperature chemical shifts and from 
imported real data points of the peaks of interest into gNMR™. A limited amount 
of exchange information could be processed from the current system.  With the 
systems 1d,e the simulations program was not set up to handle all the protons 
and the multiple conformers for determination of rotation around axis V. The 
presence of multiple conformations was simulated with line broadening which 
was consistent over multiple temperatures. 
1c also had multiple conformers at low temperatures in CD3OD and 
CDCl3. These conformers were well resolved in methanol but not in chloroform, 
which has a smaller working range of temperatures for VT-NMR. As a result, only 
the methanol set was resolved into its component rates. 1g had the potential for 
having multiple conformers in low temperature solution. The average position of 
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the two isopropyl methine resonance peaks in chloroform and in methanol shifted 
slightly as the temperature was lowered. This may indicate an unequal 
population of two sets of conformers. To compensate for this, and to reduce error 
in the calculation, the chemical shift of the two peaks was set as a variable and 
simulated in gNMR™. 
To determine the exchange rate of two inequivalent isopropyl methine 
protons, they were coupled with six equivalent protons, and the two methine 
protons were exchanged to match the peak shape of the spectrum, thus 
simulating the coalescence of two methine protons. The peaks for the part of the 
spectrum of interest were imported into the program and the program matched 
the shape and the size of the peaks by automatically calculating a probable 
exchange rate to change the size and shape of the peaks, then recalculating the 
exchange from the difference in the calculated and the experimental spectra.  
Solvent and other extraneous peaks are truncated to avoid confusing the 
program 
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Table 1.2 Experimental energy barriers for the derivative at the indicated 
axis in the indicated solvent. 
 ¨*‡rotation (kcal/mol) 
Solvent  
 
Axis 
CD3OD CDCl3 
Conc. Of protic 
material in CDCl3 
sample per 750 ul 
1b Y 10.5 (213K) * 8 mg 1b 
1c Z 10.2 (213K) 
Low exchange catalyst 
11.4 (218 K) 
12.1 (243 K) 
High exchange catalyst 
* 
 
8 mg 1c 
8mg 1c 
 
20 mg 1c 
1c Y 10.5 (225K) <10.1 (228K) 20 mg 1c 
1c (N13FiPr) 9.5 (214K) * 20 mg 1c 
1d V 14.4 (298K) 14.2 (305K) 8 mg 1d 
1d W 12.1 (250K) 12.6 (257K) 8 mg 1d 
1e V 14.0 (290K) 14.5 (295K) 8 mg 1e 
1e W 12.1 (230K) * 8 mg 1e 
1g X 10.8 (223K) 12.4 (263 K) 8 mg 1g 
1g Z 10.7 (223K) 14.3 (263 K) 8 mg 1g 
 
In the table above the symbol * indicates that the NMR peaks did not 
separate at temperatures at which CDCl3 is in the liquid state, or there was not 
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enough information to determine the rate of exchange. The pKa values for 1a-d 
were 7.2, 7.3, 8.2, and 7.4, respectively. The pKa of 1e was not determined due 
to low aqueous solubility. 
1.4 Mechanism of exchange 
The X-ray structures of 1a,c,d,  and g show a material with nitrogen atoms 
that have a flat trigonal pyramidal geometry. This indicates that N12 and N13 
(numbering from Figure 1.1) have significant p character. Furthermore, the 
mechanism of geometrical isomerization of C=N apparently switches from 
inversion to rotation as the CN bond order decreases.2,30 Three resonance 
structures distribute electrons in guanidine, so that the three CN bonds have 
bond orders greater than one and less than two. 
1.4.1 Inversion or rotation 
 
N
N
N
N
N
N N
N
N
N
N
N
‡
‡
3a
3b
3c
3d
N
N
O2N
NMe2
4
 
Figure 1.8 Mechanisms of exchange for substituents on guanidine. 
Inversion (3a to 3b to 3d) (see Figure 1.8) has been promoted as the best 
mechanism for exchange of substituents on monosubstituted nitrogen atoms of 
guanidine, whereas rotation (3a to 3c to 3d) is the only mechanism for 
disubstituted nitrogen atoms in neutral guanidine and in all guanidinium 
species.24 In one case, the barrier to rotation in a guanidine was estimated to be 
12 kcal/mol higher than the barrier to inversion!24 This result seems incredible 
given that sp2 hybridized nitrogen atoms in charge-neutral 4-nitro-4'-
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dimethylaminodiphenyldiazene 4 rotate in polar solvents and invert in apolar 
solvents.39 One of two compelling pieces of evidence for inversion in guanidine 
derivatives comes from Hammett free energy correlations in which σr stabilizes 
the transition state through electron withdrawal.2,24 Other evidence comes from 
trends observed in known barriers to inversion and rotation. Steric hindrance 
usually impedes rotation and facilitates inversion, and steric strain in neutral 
guanidine facilitates exchange of substituents on nitrogen atoms in which 
inversion is feasible. When the two disubstituted guanidine nitrogen atoms are 
connected with an ethylene linker in a basic guanidine molecule, the barrier to 
rotation is decreased by approximately seven kcal/mol.4,30 
The mechanism of geometrical isomerization of C=N apparently switches 
from inversion to rotation as the CN bond order decreases.2,30 This correlates 
well with a mechanism of heterolytic or a homolytic cleavage of the pi-bond as in 
the transformation of 3a to 3b in Figure 1.8. The isomerization barrier of phenyl-
carbonimidic acid dimethyl ester, (MeO)2CNPh, 14.4 kcal/mol, was found to be 
higher than that of phenyl dithiocarbimidoic acid dimethyl ester, (MeS)2CNPh, 
with a barrier of 13.8 kcal/mol.30 Therefore, greater resonance stabilization leads 
to a lowered barrier to rotation around the CN double bond. 
General sentiment in the literature is that disubstituted amines in 
guanidine bases rotate.3,4,30 The above mechanisms only require rotation at 
disubstituted amines. The exception to this rule is the rotation along axis Z in 
derivatives 1b,c , and along axis X and Z in 1g. Calculated barriers for this 
rotation are similar to the experimentally determined value for the barrier to 
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exchange. Again, 1b,c  are tautomerizible compounds and proton exchange can 
produce the high-energy tautomer 15. The dynamics of 15, described below, 
demonstrate another believable mechanism for the rotation around axis Z. 
Dynamic studies of 1a-g also indicated that rotation and not inversion was 
the best (most simple) explanation for the exchange of nuclei. On the N,N-
derivatives 1b,c  exchange was observed between alkyl groups on N13, and 
between protons on benzo carbons C4, C7 and between C5,C6. Rotation of axes 
Y and Z made the observed exchange match the mechanism of exchange. With 
the intramolecular hydrogen bond intact in the ground state, inversion at N10 
makes a high-energy structure, which must then rotate to get to a lower energy 
structure or invert to return to the original configuration. Calculations revealed in 
the ground state structure of 1b,c  that N10-C2 had a bond order closer to 1 than 
to 2. A lower bond order generally means rotation and not inversion.30 
There are two possible explanations for the dynamics of 1d,e. In one, the 
hydrogen bond influences the dynamics of the molecule differentiating the two 
alkyl groups on the carboxamidine functional group. In this scenario, proton 
exchange is fast, and rotation is slow along axis V. Therefore, the steric 
hindrance should also prevent the carboxamidine group from aligning parallel to 
the benzimidazole. However, this system did not act like the other systems 1c,g , 
the system was not affected by any increase in a weak proton exchange catalyst 
like methanol. In the other scenario, alkyl groups are not differentiated by the 
hydrogen bond, but by the stable imine. In this scenario, rotation is slow along 
axes U and W, and proton exchange is slow. The carboxamidine NH may be 
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much more stable than the imidazole or guanidine NH. This is the simplest 
explanation and is explained below. 
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Figure 1.9 Observed species in solution for derivatives 1d,e 
The dynamic behavior of 1d,e could be explained by the structures in 
Figure 1.9. There were two possible conformers, the CT and the TT conformer, 
and both were detected in solution at low temperatures. The CT conformer has 
one isopropyl group cis and one trans to the benzimidazole. The TT conformer 
has both groups trans to the benzimidazole. The exchange at axis V was a high 
temperature phenomenon and at axis W, a low temperature phenomenon. The 
proton the nitrogen atom adjacent to R4 was a controlling factor in all 
conformations of the molecule. The presence of this proton in 1d-e broke the 
symmetry across the plane containing the 2-aminobenzimidazole moiety in 1d-e. 
This rendered the two R groups in the TT conformer diastereotopic in 
magnetically distinct conformational space. The R groups in the CT conformer 
are of course diastereotopic regardless. In the ca. 1: 1 mixture of TT to CT two 
pairs of iPr methine signals are visible at low temperature. If proton exchange 
was very slow on the carboxamidine moiety then the presence or absence of the 
proton exchange is important for the exchange phenomena that occur between 
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R3 and R4. Steric interactions between the benzo CH and the carboxamidine NH 
or R4 keep R3 and R4 diastereotopic. The rotation of the carboxamidine group 
along axis V of the TT conformer perpendicular to the benzimidazole makes the 
two R groups equivalent assuming fast proton exchange. Dynamic 1H NMR 
supported these conclusions. 
1.4.2 Conjecture regarding the rotational transition state of 1b-c 
A set of tautomers was investigated computationally for 1b,d , and f to 
determine which was the lowest in energy and had the lowest barrier to rotation. 
The barriers to rotation could be determined experimentally for a set of 
structures, and ab initio calculations determined the barrier for individual 
tautomers. Barriers to rotation could be experimentally determined by monitoring 
the slow exchange of a set of protons in the 1H-NMR, and calculated ab initio 
with a modeling program that optimized the structure at 6-31G* theory level. 
Calculations were run by the method described below, to determine the rotational 
transition state. VT-NMR experiments, as described section 1.5 in were used to 
experimentally determine the barriers to rotation. The comparison of the barriers 
determined by experimental and ab initio methods were used to generate 
theories on the strength of the intramolecular hydrogen bond and the 
mechanisms of exchange in the 1H-NMR. 
1.4.3 Ab-initio  studies of energy barriers to rotation about C-N partial 
double bonds 
Using the Gaussian98 program13 for molecular modeling a barrier to 
rotation was determined for N,N-dimethyl-N’-2-benzimidazoyl at two different 
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bonds. First the ground state for the molecules was found by an optimization of 
the molecule starting from a planar state and optimizing at the B3LYP/6-31G* 
level of theory. For this conformation, the energy was calculated at the MP2/6-
311++(2d,2p) level. To determine the barrier to rotation about the Z-axis, the N1-
C2-N10-C11 dihedral angle was set and frozen at 90º and then optimized, at the 
B3LYP/6-31G* level of theory, with that dihedral angle still frozen. The energy for 
this conformation was then calculated at the MP2/6-311++(2d,2p) level; 
subtracted from the calculation of the energy of the planar structure also 
calculated at this theory level. This procedure was repeated for the C2-N10-C11-
N12 dihedral angle for 1b. 
The intramolecular hydrogen bond appears to still affect the molecule 
even with the dihedral angle of C2-N10-C11-N12 set to 90º out of the plane. N1-
N12 bond distance for 1b was 3.33 Å versus 2.70 Å when the dihedral angle is 
not constrained. N1-N12 bond distance was 2.67 Å in the crystal structure for 1c. 
Both of these distances are within the definition of a hydrogen bond. 
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Table 1.3 Energy (kcal/mol) of tautomers vs. a ground state tautomer from 
Ab initio  modeled structures. 
Bond 
Compound 
C2í110 
Flat 
C2í1 
Twisted 
N10í& 
Twisted 
13b or 1b 0.0 9.0 17.1 
15b 13.9 14.2 No calculation 
1f 0.0 9.4 18.7 
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Figure 1.10. Mechanisms for exchange in N,N-substituted 
guanidinobenzimidazole 
In table 1.3 and 1.4 all energies are referenced to the ground state 
tautomer 1b and 1f, which are the N,N-dimethyl derivative, and N,N’-dimethyl 
derivatives. Calculations were done at MP2/6311G++(2d, 2p) in the gas phase. 
Subtract the flat ground state energies from the twisted transition state energies 
to calculate particular energy barriers. Subtract the energies of the tautomers to 
appreciate which tautomer may likely dominate the equilibrium mixture. Bear in 
mind that the observations were made in solution, not the gas phase. 
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Table 1.4 Energies calculated with simulated solvent PCM method 
Bond 
Compound 
C2í1IODW û+RIVROYDWLRQ 
1b or 13b 0 -12.66 
15b 12.8 -15.58 
1f 0.0 -12.75 
 
Calculated energies (kcal/mol) of tautomers in Figure 1.10. The lowest 
energy tautomer in each substitution pattern was assigned zero energy; the 
energies of the other tautomers were referenced to these. Calculations were 
done at the 6í*WKHRU\OHYHOXVLQJthe Polarized Continuum (overlapping 
spheres) model (PCM) with water dielectric. The cavity was built up by putting a 
sphere around each solute atom, using UAHF radii when available and UFF radii 
otherwise with a scaling factor of 1.0 for protic hydrogen atoms and 1.2 for all 
other atoms. For a complete discussion of these methods see: 
http://www.gaussian.com/00000474.htm. 
The exchange between tautomers 13-17, shown in Figure 1.10, represent 
the two observed exchange mechanisms for  N,N-dialkylated 
guanidinobenzimidazoles, and the tautomeric pair that most likely undergoes the 
rotational exchange. For calculations sake tautomers 13b, 15b, and 16b were 
calculated using R=methyl for tautomers of 1b to reduce calculation time and 
memory requirements. Ab initio calculations show that tautomer 15b should have 
facile rotation around axis Z, and the intramolecular hydrogen bond in 15b should 
be very weak. Calculations showed that rotation along axis Z only raises the 
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energy of 15b by 0.3 kcal/mol. Tautomers 13b, 14b were lower in energy in the 
gas phase than 15,16 by 10.0 and 13.9 kcal/mol, respectively, but conversion of 
15b to 16b is energetically downhill by 3.9 kcal/mol. The calculated barrier to 
rotation along axis Z for 13b was 9.0 kcal/mol and was within 1.2 kcal/mol of the 
experimental value of 10.5 kcal/mol. In solution, 15b maybe accessible, but 
rotation of axis Z from 13b seems to be the best explanation of the dynamics of 
the C2-N10 bond. 
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Figure 1.11 Is proton exchange occurring in the crystal structure? 
The crystal for 1c showed a feature in the difference maps of the 1d 
crystal that indicated possible proton exchange along the intramolecular 
hydrogen bond in the crystal structure. The feature was in the right position to 
indicate proton exchange was occurring. If proton exchange does occur there 
would be extra electron density on the N10-C2 bond. Figure 1.11 shows the 
electronic structure that explains the effects of proton exchange on the rotation at 
axis Z. A normal proton exchange can occur under the conditions of bond 
vibration of the intramolecular hydrogen bond.  Proton exchange along the 
intramolecular hydrogen bond of the low energy tautomer 1b would generate 
structure 24. This vibration should be possible even under the tight packing 
conditions of a solid crystal because motion along the hydrogen bond trajectory 
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does not produce much motion in the entire molecule. In solution, this tautomer 
was transient and did not appear to have any impact on the dynamics of the 
molecule. 
Most measurements were taken in the presence of fast proton exchange 
using CD3OD. Running the experiments at low dilutions raised the barriers for 1d 
by 1 to 2 kcal/mol for the benzo protons. 1g had a greater change in its barrier to 
exchange. The change from protic to aprotic conditions increased the barrier to 
exchange for the alkyl groups R5, R2 by two kcal/mol to 12 kcal/mol and the 
benzo protons by four kcal/mol to 14 kcal/mol.  
CT and TT conformers of 1f were analyzed using an ab initio calculation; 
methodology was the same as for the above conformers. Calculations showed 
the CT to be 1.3 kcal/mol lower in energy than the TT conformer. Both 
conformers of 1f were seen in solution with the ratio changing with different 
solvents. TT was preferred in methanol, and CT was preferred in chloroform.  
1.5 VT Data and analysis 
1.5.1 Solvent dependant conformational preference of 1d 
1H-NMR spectra were taken at low temperatures to identify the ground 
state conformation, to investigate solvent sensitivity, and to explore the 
differences between different substitution patterns of 2-aminobenzimidazole. 
Solvent had an obvious influence on some of the conformers of 1d. The solvent 
affected changes in the conformation of the isopropyl groups, when the solvent 
was changed from CD3OD to CDCl3. The TT conformation was preferred over 
the CT conformation in CD3OD, and in CDCl3 a less sterically hindered CT 
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conformer was preferred. Spectrum C, Figure 1.13, taken at -50 Û&LQ&'3OD 
shows the CT conformer was slightly favored over the TT conformer. Apolar 
solvents like CDCl3 switched the equilibrium to favor the CT conformer over the 
TT conformer (see Figure 1.11 spectrum b); compare the methine signals of the 
iPr groups at 4.2-3.0 δ in spectrum b in Figure 1.12 (CDCl3) to those in spectrum 
c in Figure 1.13. Conformers CT and TT were assigned by NOE. At -50 °C in 
MeODd4, TT and CT produced separate 1H NMR signals (1.3: 1.0 ratio, TT: CT). 
A NOESY experiment at -70 °C (see appendix) confirmed the proximity of the 
two iPr substituents in TT. The two most intense iPr methine protons were 
assigned to TT because these correlated with two methyl signals in the NOESY 
experiment. The other two methine iPr signals shared cross peaks with one 
methyl signal. Cross peaks from chemical exchange between the two methine 
protons from the major and the minor rotamer appeared in the NOESY spectrum. 
The low-temperature NOESY spectrum is available in the appendix. 
1.5.2 Variable temperature 1H NMR of 1d in CDCl 3 
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Figure 1.12. Stacked spectra showing the dynamic exchange in 1d in CDCl 3. 
Stacked spectra in Figure 1.11, showed the dynamic exchange in 1d in 
CDCl3 as the temperature was decreased. The inset at 35 °C (spectrum a) 
clearly showed the first order pattern in the benzo protons. A single benzo proton 
was broadened by the presence of the two different conformers. The signals from 
the isopropyl groups were broad features at 35 °C, but cooling to -55 °C 
(spectrum b) suspended the exchange in the methyl and methine protons on the 
NMR timescale. There was a broad protic signal riding on the downfield edge of 
the most downfield methine signal at ~4.1 δ. The protic peak at 6.5 δ was 
assigned to the intramolecular hydrogen bond.  
In 1c,g  the exchange rate of exchangeable benzo protons increased as a 
proton exchange catalyst was added in aprotic solvents like CDCl3. Addition of 
DMSO, an inhibitor of proton exchange led to a downfield shift of the downfield 
chemical shifts in 1c. In 1c,g  the protic chemical shifts varied as a function of 
temperature. In 1d, one of the protic signals (~2H, δ 6.5, -55 °C) changed -11.1 
ppb/K in CDCl3, which was approximately 6.3-fold larger than the temperature-
dependence of the chemical shift of an upfield protic signal, approximately -1.8 
ppb/K (1H, δ 4.05). Temperature-sensitivity of the analogous downfield protic 
signals in 1c (1H, δ 10.0, -30 °C) and (2H, δ ~7.3, -30 °C) in CDCl3 was -25 
ppb/K for the downfield shift. The upfield protic shift at δ 7.3 was much less 
temperature-dependent, but broadened considerably upon cooling. These 
protons behaved like the quickly exchanging protic signal of methanold3 in 
CD3OD NMR solvent. The upfield protic signal in 1d behaved differently than the 
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protic signal in the free solvent and was probably due to the proton in 
intramolecular hydrogen bond. Attempts to unambiguously assign these protic 
signals failed.  
1.5.3 Variable temperature 1H NMR of 1d in CD 3OD 
 
Figure 1.13. Stacked spectra showing the dynamic exchange in 1d in 
CD3OD. 
Stacked spectra showed the dynamic exchange in 1d in CD3OD as the 
temperature was decreased. The series from spectrum a at 45 °C to spectrum b 
at 0 °C to spectrum c at -55 °C clearly showed two dynamic processes. The first 
exchange (spectrum c to b) involved an equilibrium of CT and TT, and the next 
exchange (spectrum b to a) involved TT and TT’. 
There were four signals, two pairs (1.2: 1.0), for the iPr methine protons of 
1c in CD3OD at -50 °C. These appeared to arise from hindered rotation of the iPr 
substituents. One of the iPr methine protons in CT and TT was proximal to the 
benzimidazole deshielding cone. Probably the deshielding cone of the 
36 
benzimidazole shifted these methine protons downfield by ~ 1 ppm of the other 
iPr methine signals. Molecular modeling demonstrated that the interatomic 
distance between benzimidazole H4 and the methine proton in CT was ~2.6 Å, 
and the analogous distance for TT was ~2.8 Å. Stark changes in magnetic 
anisotropy tend to occur above or below the π-system, and the isopropyl groups 
were restricted into those areas. 
1.5.4 Variable temperature 1H NMR of 1b in CD 3OD 
 
Figure 1.14 Stacked spectra showing the dynamic exchange in 1b 
Stacked spectra showed the dynamic exchange in 1b in CD3OD as the 
temperature was decreased. Two mechanistically unrelated asynchronous 
processes exchanged the methyl substituents on the guanidino terminus and the 
protons in the benzene ring. From spectrum a to spectrum c the pattern in this 
aromatic region changes from AA’BB’ to ABCD, and protons C and D were 
broadened but still occurred at the same frequency. Only an upper limit could be 
placed on the exchange of the protons in the benzene ring.  
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1.5.5 Temperature sensitivity of protic peaks 
Exalted temperature-sensitivity in chemical shifts of intramolecular 
hydrogen bonds has been reported.37 Chemical shifts of hydrogen bonded 
protons occur downfield of analogous protons bound to only one electron donor 
because the hydrogen atom partially dissociates from the hydrogen bond donor 
atom toward the hydrogen bond acceptor atom. The chemical shift of a proton 
involved in a hydrogen bond varies inversely with temperature, if the hydrogen 
bond is not a low barrier hydrogen bond.27 The hydrogen in the intramolecular 
hydrogen bond in 1d in CDCl3 was found 2.2 ppm downfield of the next most 
downfield protic signal in 1d. The slope of the temperature dependence of the 
chemical shift for the intramolecular hydrogen bonded proton was -11.1 ppb/K in 
CDCl3, which was approximately 6.3-fold larger than the temperature 
dependence of the chemical shifts of the other protic signals, approximately -1.8 
ppb/K. 
1.6 Conclusion. 
An intramolecular hydrogen bond was analyzed under conditions of fast 
and slow hydrogen atom exchange. We determined that the rate of exchange of 
the alkyl groups and benzimidazole protons was influenced by the amount and 
rates of hydrogen atom exchange in 1a-g, making an analytical determination of 
the hydrogen bond strength difficult.  Despite the obvious influence of proton 
exchange, the molecule’s dynamics was influenced by the hydrogen bond.  
The explanation for the dynamics of guanidinobenzimidazole is a 
combination of the effects of a dynamic intramolecular hydrogen bond, hydrogen 
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atom exchange, and quite possibly solvent polarity. If guanidinobenzimidazole 
and its derivatives had the dynamics that would correspond to a structure 
indicated by the tautomer shown in Figure 1.1, then the rotation about axis Y and 
Z would be fast, and rotation about axis X would be very slow. However, the 
situation is not that simple and the dynamics of the system are more complex. 
The effect of a resonance-assisted hydrogen bond (RAHB) was useful in the 
explanation of the dynamics of the molecule. Although a direct measurement of 
the strength of the intramolecular hydrogen bond was not possible, the dynamics 
of the molecule was useful in finding evidence for the presence of the RAHB in 
solution. If the RAHB is present, it does not possess the normal strength of a 
RAHB. Even under slightly protic conditions of 8 mg / 750 L chloroform, the 
exchange is faster for the alkyl groups along axis X than along axis Z. This 
implies that bond order has been reduced between C11 and N10 (numbering 
from Figure 1.1) and a tautomer like structure 24 in Figure 1.11 is found. In lower 
polarity aprotic solvents, this mechanism may be promoted while in polar protic 
solvents many tautomers exist with other mechanisms for exchange exist. 
Therefore, with redundant mechanisms the potential for exchange increases, as 
does the rate of exchange. Our dynamic results are similar to those described 
earlier for the dynamics of 15N-NMR spectroscopy of 1a described earlier in 
chapter 1.  
In 1d,e the exchange of the alkyl groups is remarkably well controlled in 
comparison to the conformational control offered by the hypothetical planar 
resonance stabilized hydrogen bond did not appear to contribute as much to the 
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conformational stability as the hydrogen bond that was not resonance stabilized 
or planar. This was a rather remarkable discovery, but the explanation was quite 
simple. The carboxamidine functional group had a different pKa than the 
guanidine and this led to remarkable dynamics, which appeared unchanged by 
differing amounts of a weak proton exchange catalyst. There were at two least 
two possible explanations for this behavior. The first rationalization focuses on 
the differences between the intramolecular hydrogen bond acceptors in the 
derivatives of 1 studied in this thesis. Other arguments were more complex. In 
another explanation, the secondary imine nitrogen atom may participate in a 
kinetically more stable hydrogen bond than the primary imine nitrogen atom. The 
second rationalization focuses on the nature of the hydrogen bond in planar, five 
or six centered intramolecular hydrogen bonds. The heteroatoms in these 
species may simply be too close for optimal hydrogen bonding. This may be born 
out in calculations since the atoms are not all coplanar after optimizing the atomic 
positions at a high level of theory. If the bonding pattern positions the 
heteroatoms involved in the hydrogen bond too close, the hydrogen bond is 
established at the expense of conjugation (non-planar structure) and conjugation 
is optimized at the expense of the hydrogen bond. In the absence of the solvent 
shell, (x-ray structures, gas-phase calculations) the optimum distance dAB of the 
hydrogen bond likely shortens, making the hydrogen bonds give rise to more 
planar structures. The third explanation says that the mechanisms and the rates 
of exchange are different for the three types of six-centered intramolecular 
hydrogen bonds. 
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Rotation was found to be the best mechanism for basic guanidines 
involved in a six-centered intramolecular hydrogen bond. The barrier to rotation 
was measured for two different heterocycles. Barriers to exchange matched well 
with the calculated values for the barrier to rotation. These studies provided a 
realistic vision of what to expect of intramolecular hydrogen bonds in the control 
of de novo designed conformations. If any hydrogen bond will operate to control 
conformation, the ones that participate in planar aromatic structures should 
contribute the most to conformational control. In general, the six-centered 
intramolecular hydrogen bonds studied here were not stable enough to be used 
for the design of compounds needing conformational stability.  
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Chapter 2  
Synthesis of benzimidazole derivatives 
Guanidinobenzimidazole has complex chemical reactivity. The guanidine 
moiety is difficult to selectively alkylate, and the basicity is more like imidazole 
than guanidine. Guanidinobenzimidazole has a pKa of 7.09,1 while that of 
benzimidazole is 5.561, and that of guanidine is 14.381. Alkylated derivatives can 
be formed in several ways. The optimum method used to form the 
guanidinobenzimidazole depends upon the substitution pattern desired. The 
most nucleophilic atom on 2-guanidinobenzimidazole is the non-protonated 
imidazole nitrogen (N1, numbering system shown in Figure 1.1). The 
nucleophilicity of N1 was used to methylate this nitrogen, using a strong 
unhindered electrophile like methyl iodide. Other derivatives formed from this 
reaction were not isolated due to difficulty in purification. 
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Figure 2.1 Synthesis of 2-amino-1-benzimidazole- N,N’-dialkylcarboxamidine 
derivatives 
Methods to selectively and directly alkylate the terminal nitrogen atoms on 
the guanidine moiety, N12, N13 have not been discovered, due to their lower 
nucleophilicity. With reactivity again reflective of the nucleophilicity of N1, 1d-f  
were synthesized by the condensation of the corresponding N,N’-disubstituted 
carbodiimide 22d-f . 22f appears to be particularly labile to solvolysis for N,N’-
derivative 1f. These derivatives required a moderately bulky substituent for 
isolation of a product. Larger alkyl groups appeared to decelerate the solvolysis 
of 1d-f . N,N’-Dimethyl derivative 1f was detected in solution, but purification 
methods decomposed the chemical. N,N’-Diisopropyl derivative 1d decomposed 
over several hours at raised temperatures in protic solvents, but was stable to 
silica chromatography. However, because it crystallized pure from non-polar 
aprotic solvents, chromatography was not necessary, and the material could be 
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obtained in excellent purity. p-Tolyl derivative 1e was less stable to silica and 
small impurities persisted after silica chromatography, presumably due to the 
decomposition on the column. 
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Figure 2.2 Literature evidence for 2-amino substitution. 
Substitution at N1 was unexpected for the reaction of carbodiimides with 
2-aminobenzimidazole. Dimethylcyanamide reacted with 2-aminobenzimidazole 
when heated in neat dimethylcyanamide at 105 °C at the 2-amino position to 
form 1b granted in low yield and impure. Acetylation of the same molecule 
proceeded with substitution at N1, but heat caused a rearrangement with 
substitution at the 2-amino position.2 With the carboxamidine cation being more 
stable than the N-acetyl cation the rearrangement should have been more facile. 
2-Amino substitution was expected. In the crystal structure, seen below in Figure 
2.3, the product was highly strained with no favorable intramolecular hydrogen 
bonding interactions and decreased π-conjugation.  
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Figure 2.3 Crystal structure of 2-amino-1-benzimidazole- N,N’-
diisopropylcarboxamidine 
There are at least four different intermolecular hydrogen bonds for every 
molecule of 1d. This does not include another hydrogen bond to the carbonyl of a 
molecule of ethyl acetate. Planarity and the cohesion of the intramolecular 
hydrogen bond between the carboxamidine and the 2-amino protons in 1d is 
probably disturbed by the intermolecular hydrogen bonding just described. 
 
Figure 2.4 Crystal structure of 1g. 
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Another product is formed when the reaction to make 1d was repeated at 
110 °C, refluxing a melt of the two starting materials. This product was identified 
as the 2-aminobenzimidazole with the carbodiimide substituted at the 2-amino 
position, 1g, shown in figure 2.1. Although the yield was low at around 12% yield, 
improvements in the methodology should improve the yield. The crystal structure 
for 1g is shown above in Figure 2.4. 
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Figure 2.5: Synthesis of N,N-dialkyl guanidinobenzimidazoles 
Substitution at only N13 was accomplished with alkyl groups of moderate 
to high steric hindrance. N,N-dialkyl-2-guanidinobenzimidazole derivatives 1b,c 
were synthesized, as shown in Figure 2.4 above, by the condensation of ortho-
phenylenediamine and an N,N-dialkyl-dicyandiamide. This method has been 
shown to be useful in the synthesis of 2-(N-isopropylguanidino)benzimidazole3 
and also to make the corresponding dimethyl, isobutyl, piperidino, cyclohexyl, 
and morpholino derivatives.4 
1b was also synthesized using a similar method with 2-
aminobenzimidazole and dimethylcyanamide. N,N-Dimethylguanidino-N’-(2-
benzimidazoyl) 1b was formed by the condensation of 2-aminobenzimidazole 
and dimethylcyanamide in low yield. Synthesis of 1c using diisopropylcyanamide 
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was unsuccessful. Heat and Lewis acid catalysis resulted in starting material and 
decomposed starting material. 
Two 2-amino-1-benzimidazole-N,N’-dialkylcarboxamidine derivatives were 
synthesized by the condensation of N,N’-dialkylcarbodiimides 22 and 2-
aminobenzimidazole 23. The synthesis of 1d,e by the reaction of 2-
aminobenzimidazole with a carbodiimide with alkyl substituents of high steric bulk 
(for example, 22d) ran in high yield. For the synthesis of 2-(N,N- 
dialkylguanidino)benzimidazoles with large alkyl substituents the reaction of 
phenylenediamine and N,N-diisopropyldicyandiamide ran in poor yield. For the 
synthesis of 8-(N,N-dialkylguanidino)purines, the reaction of 4,5-
diaminopyrimidine and N,N-isopropyl, t-butyldicyandiamide ran in high yield. 
2.1 Synthesis of N,N-dialkylguanidinobenzimidazoles from N,N-dialkyl- N’-
cyanoguanidines and o-phenylendiamine. 
Cyanoguanidines (Dicyandiamides) are typically made from the reaction of 
an amine hydrochloride and sodium dicyanamide in refluxing alcohol. The yields 
for this reaction are moderate, however decomposition products at the end of the 
reaction do not hamper isolation. The only impurities in the product are the 
starting materials. The N,N-dialkyl-N’-cyanoguanidine product also called N,N-
dialkyldicyandiamide can be purified by extraction into ethyl acetate and 
crystallization. A series of N,N-dialkyl-N’-cyanoguanidines were made with the 
varying yields shown in Table 2.1. 
Table 2.1 Synthesis of N,N-dialkyl- N'-cyanoguanidines 
Derivative Alkyl group % yield 
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26b R = Methyl 25 
26g R = Ethyl 50 
26c R = isoPropyl 42 
26h R = tertButyl 17 
 
The less sterically hindered N,N-dialkyl-N’-cyanoguanidines were useful in 
the synthesis of N-(1H-benzimidazol-2-yl)-N',N'-dialkyl-guanidines. When the 
N,N-dialkyl-N’-cyanoguanidines were refluxed in water with 4 equivalents of HCl 
and one equivalent of o-phenylenediamine the cyanoguanidines condensed with 
the o-phenylenediamine losing ammonium chloride. When N-t-butyl,N-isopropyl-
N’-cyanoguanidine and N,N-dit-butyl-N’-cyanoguanidine were submitted to the 
same conditions, no reaction took place. The following derivatives were isolated 
in the following yields. 
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Table 2.2 Synthesis of N,N-dialkylguanidinobenzimidazoles 
Derivative Alkyl group % yield 
1a R = Methyl 10-25 
1c R = isoPropyl 10-16 
1h R = tButyl 0 
 
2.2 Synthesis of 2-amino-1-benzimidazole- N,N’-dialkylcarboxamidine from 
2-aminobenzimidazole and N,N’-dialkylcarbodiimides or N,N’-
dialkyluronium chloride salts. 
Guanidines can also be synthesized by using carbodiimides and uronium 
chloride salts. These reactions were facile and high yielding when the alkyl group 
on the carbodiimide had moderate steric bulk. 2-Amino-1-benzimidazole-N,N’-
diisopropylcarboxamidine (1d) was synthesized using commercially available 
N,N’-diisopropylcarbodiimide and 2-aminobenzimidazole. Within 12 h the 
reaction had gone to completion by TLC. The crude yield was about 85%. The 
crude residue was purified by recrystallization with ethyl acetate. The ethyl 
acetate was removed by dissolving in CHCl3, pumping off the residue under high 
vacuum, crushing the residue to a powder and again evaporating under high 
vacuum.  
N,N’-Di-p-tolylcarbodiimide, 22e also reacted with 23 in refluxing THF 
overnight, and was crystallized from wet ethyl acetate. A small amount of 
hydrolyzed product also resulted from this crystallization, but other methods only 
precipitated powder. The yield of this product was good at 76%. The more 
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sterically hindered N,N’-di-tert-butylcarbodiimide did not react with 23 under 
refluxing THF, or DMF heated to 60 °C.  
N,N’-Dimethylcarbodiimide was synthesized according to a literature 
procedure5 for the synthesis of 2-amino-1-benzimidazole-N,N’-
dimethylcarboxamidine, 1f. N,N’-dimethylthiourea and HgO (dried at 150 °C for 2 
h) were stirred at 0 °C to room temperature over 45 min The precipitate was 
filtered and concentrated by slow distillation from a bath temperature of 50-55 °C. 
This material was used as is and stirred with 2-aminobenzimidazole in CHCl3 
overnight under N2. The resulting product was filtered and dried under vacuum. 
The 1H NMR in DMSOd6 showed mostly the 2-aminobenzimidazole with a 
product that could not be isolated pure. 
The N,N’-dimethyluronium chloride was synthesized according to a 
literature procedure6 for the synthesis of 1f. N,N’-Dimethylthiourea (107.3 mg, 
1.030 mmol) was dissolved in 10 mL dry THF. Triphosgene (328.5 mg, 1.107 
mmol) in 5 mL dry THF was added to the thiourea slowly by syringe. The 
reactions was stirred for 1 h and refluxed for 3 more. The reaction formed a 
precipitate that was dissolved with CHCl3, and again precipitated with THF. The 
precipitate was filtered under nitrogen and recrystallized with the CHCl3 and THF 
solvent mixture for a total yield of 202.6 mg, 1.901 mmol or 68% yield with 
respect to the thiourea. When stirred with 2-aminobenzimidazole the N,N’-
dimethyluronium chloride reacted in a manner similar to N,N’-
dimethylcarbodiimide. The reaction was incomplete and the product was 
unstable to purification. 
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2.3 Synthesis of N,N’-diisopropylguanidinobenzimidazoles 
 
2.3 Synthesis of 1-methyl-2-guanidinobenzimidazole 
N
H
N
N
H2N
NH2
MeI,
KOtBu
N
N
N
H2N
NH2
1a 28
 
Figure 2.6 Alkylation of 1a with methyl iodide 
Deprotonation of the imidazole nitrogen N1, in 1a, resulted in N-
methylation of N1 upon treatment with methyliodide.  This reaction was 
regioselective for alkylations at the imidazole nitrogen. One equivalent of 1a, and 
Potassium tert-butoxide and a catalytic amount of 18-crown-6 was dissolved in 
THF. An equivalent of methyliodide was added drop-wise to the reaction at 0 °C. 
After 5-10 minutes a white precipitate had formed. 1-methyl-2-
guanadinobenzimidazole, 28, was neutralized and purified by crystallization from 
ethyl acetate and hexane (53% isolated yield). 
2.4 Synthetic procedures and data 
2.4.1 Synthesis of N-(1H-benzoimidazol-2-yl)- N',N'-dimethyl-guanidine (1b) 
N
N
N
NH
N
H
H
NH2
NC
NH2
N
NH
N
H
NC N-
CN
+H2NCl
-
Na+
1b
+
1N HCl
Heat 2hrs.
+
butanol
reflux
24
25b 27
26b
 
Figure 2.7 Synthesis of 1b 
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Dimethylamine (2.60 mL, 40% aqueous solution) sodium dicyanamide 
(1.78 g, 20.0 mmol), and HCl (1.76 mL, 37% aqueous solution) were refluxed for 
24 h. This solution was neutralized with Na2CO3 (2M) and extracted into n-
butanol. The n-butanol layer was washed with brine and evaporated. The crude 
N,N-dimethyldicyandiamide (0.566g, 5.05 mmol, 25% yield) was crystallized from 
n-butanol and ethyl acetate. N,N-dimethyldicyandiamide (431 mg, 3.85mmol) and 
phenylene diamine (401 mg, 3.71 mmol) and 310 / of conc. HCl was dissolved 
in 4.0 mL distilled water. The reaction was refluxed for 6 h then neutralized with 
sodium carbonate and water, extracted with ethyl acetate and dried with MgSO4. 
After silica gel chromatography (5% TEA in EtOAc) the solution was 
concentrated and N-(1H-benzoimidazol-2-yl)-N',N'-dimethyl-guanidine (84.1 mg, 
0.381 mmol, 10% yield) was obtained as crystalline material. 
1H-NMR (300 MHz; CDCl3) δ 7.22 (2H, dd, J=6.1, 3.2 Hz), 6.94 (2H, dd, 
J=6.0, 3.2 Hz), 3.27 (6H, s) m/z (EI) 259 (M+, 1%), 133 ((M - diisopropyldiimidyl)+, 
83%) 13C NMR (75.4 MHz; CDCl3) δ156.702, 156.0, 117.3, 109.7, 33.8. IR(KBr 
pellet)2924.9, 2867.5, 1529.9, 1459.3, 1388.6, 1261.2, 1215.2, 1051.5 cm-1 Anal. 
Calcd. For C10H13N5 C, 58.80, H, 6.91, N, 34.29 found C, 58.97, H, 6.47, N, 
34.07. 
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2.4.2 Synthesis of N-(1H-benzoimidazol-2-yl)- N',N'-diisopropyl-guanidine 
(1c) 
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Figure 2.8 Synthesis of 1c 
Sodium dicyanamide (4.34 g, 49.3 mmol) and diisopropylamine (4.85 g, 
48.0 mmol) and 4.0 mL concentrated HCl (50 mmol) were refluxed in n-butanol 
for 28 h. The solution was washed with distilled water and then 3x with brine 
resulting in a pink aqueous phase and a pale clear yellow organic phase. N,N-
diisopropyldicyandiamide (2.33 g, 13.8 mmol, 29%) was crystallized from hot 
ethyl acetate. N,N-Diisopropyldicyandiamide (211.7 mg, 1.26 mmol) was refluxed 
for 2 h with o-phenylenediamine (140.8 mg, 1.30 mmol) in 2 equiv. HCl(aq) (2.0 
mL, 0.66 M). The reaction was worked up with Na2CO3 washed three times with 
ether, and then with brine. The solution was concentrated and purified by flash 
silica gel chromatography (4: 1, hexane: EtOAc and 5% TEA). The first fraction 
(232 mg, 0.894 mmol) 71% crude yield was recrystallized from hexane and 
EtOAc. 
1H NMR (300 MHz; CD3OD) δ 7.99 (dd, 2H, 7.1 Hz, 25.5 Hz), 7.61 (dt, 2H, 
2.2 Hz, 6.9 Hz), 4.21 (septet, 2H, 6.8 Hz), 1.34 (d, 12H) 13C NMR (75.3 MHz; 
CDCl3) δ 156.7, 146.6, 131.3, 129.3, 59.0, 26.5, 22.4 IR(KBr pellet) 3493.6, 
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3393.2, 3120.11, 2973.0, 1626.2, 1606.8, 1516.2, 1486.3, 1457.9, 1388.6, 
1272.1, 1215.2, 1136.2 cm-1 Anal. Calcd. for C22H21N5 C, 64.84, H, 8.16, N, 
27.00 found C, 64.76, H, 8.06, N, 26.92. 
2.4.3 Synthesis of 2-amino-1-benzimidazole- N,N’-
diisopropylcarboxamidine(1d) 
N
N
NH2
N
H
NN
H
N
N
C N
NH2 1d
+
CHCl3
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22d
23
 
Figure 2.9 Synthesis of 1d 
2-amino-benzimidazole (1.11 g, 8.31 mmol) was dissolved in a solution of 
THF with two molar equivalents of N,N'-diisopropylcarbodiimide. Within 12 hours 
the 2-amino-benzimidazole was completely used up by TLC. Water was added to 
the mixture and the product was extracted into CHCl3. The crude yield was about 
85%. The crude residue was purified by recrystallization with ethyl acetate. The 
ethyl acetate was removed by the pump freeze thaw method several times.  
1H NMR (300 MHz; CDCl3, 25 Û&δ 7.40 (d, 1H), 7.27 (broad d, 1H), 7.14, 
(t, 1H), 7.05 (t, 1H), 5.2-6.0 (broad s, 2H, NH), 3.2-4.2 (broad m, 4H),1.0-1.4 
(broad s, 12H); 13C NMR (75.4 MHz; CDCl3) δ 160.6, 153, 141.9, 133.1, 122.6, 
116.7, 109.7 (vb), 47.0 (vb), 24.1 (b); IR -3500-3300, 3080, 1640-1700, 1554, 
1458, 740; Anal. Calcd. for C14H21N5 C, 64.83, H, 8.16, N, 27.01 found C, 64.51, 
H, 8.31, N, 26.55. 
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2.4.4 Synthesis of 2-amino-1-benzimidazole- N,N’-ditolylcarboxamidine (1e) 
N
N
NH2
N
H
N
N
H
N
N
C N
NH2
1e
+
DMF
12 hrs.
22e
23  
Figure 2.10 Synthesis of 1e 
2-Amino-benzimidazole (299.1 mg, 2.25 mmol) was dissolved in a solution 
of 2.5 mL DMF with an excess of N,N’-ditolylcarbodiimide (499.9 mg, 2.25 mmol). 
The DMF was evaporated under high vacuum, and the resulting solid was 
crystallized from wet ethyl acetate. 1e (607.3 mg, 1.71 mmol) was recovered for 
a yield of 76.1%. This material was recrystallized with ethyl acetate and hexane 
and ethyl acetate and chloroform. The ethyl acetate was removed by the pump 
freeze thaw method several times.  
1H NMR (300 MHz; CDCl3) δ 7.29 (t, 1H, 8.0 Hz), 7.22 (t, 1H, 8.0 Hz), 7.14 
(vb, 4H, 9.8 Hz), 7.07 (t, 1H, 9.8 Hz), 7.05 (t, 1H, 6.8 Hz), 6.90 (vb, 2H),  6.66 
(vb, 2H) , 2.31 (vb, 3H),  2.17 (vb, 3H), 1.34 (d, 12H) 13C NMR (300 MHz; CDCl3) 
δ 172.3, 172.2, 138.7, 132.5, 131.6, 129.3, 125.2, 71.5, 29.4 Anal. Calcd. for 
C22H21N5 C, 74.34, H, 5.96, N, 19.7 found C,74.48, H,6.30, N,19.62. 
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2.4.4 Synthesis of N-(1H-benzoimidazol-2-yl)- N',N'-diisopropyl-guanidine 
(1g) 
N
N
N
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N
N
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N
N C
N
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+
Neat, 
48 hrs.
22e
23  
Figure 2.11 Synthesis of 1g 
2-Amino-benzimidazole (522.8 mg, 3.93 mmol) was stirred with 
diisopropyl carbodiimide (450 mg, 4.0 mmol) neat for 48 h at 110 °C.  The 
reaction was held under a static nitrogen atmosphere with the carbodiimide held 
under a condenser. Excess carbodiimide, 22e, was evaporated under high 
vacuum, the resulting solid was dissolved in 100 ml ethyl acetate filtered and 
addition of a small amount of hexane caused the formation of a suspension 
which over time, formed an oily layer on the bottom of the flask. The liquor was 
decanted and further addition of hexane caused the crystallization of 1g from 
ethyl acetate. 1g (117mg, 0.45 mmol) was recovered for a yield of 12%. This 
material was further purified by crystallization with ethyl acetate and hexane. The 
crystals were of a yellow brown color and melted at 162°C. X-ray analysis 
revealed the form of the chemical shown above in Figure 2.10. Residual ethyl 
acetate was removed by dissolving with chloroform and evaporating under high 
vacuum, crushing this material into a powder and again evaporating under high 
vacuum. 
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1H NMR (400 MHz; CD3OD) δ7.20 (m, 2H, 3.2 Hz), 6.95 (m, 2H, 3.2 Hz), 
4.02 (septet, 2H, 6 Hz), 1.23 (d, 12H, 7 Hz) 13C NMR (400 MHz; CD3OD) δ 
158.76, 155.15, 137.54, 120.07, 111.91, 42.61, 22.10; IR 3431, 2971, 1598, 
1529, 1461, 1402, 1367, 1273, 1176, 736; Anal. Calcd. for C14H21N5 C, 64.83, H, 
8.16, N, 27.01 found C, , H, , N, ; EI Mass Spectra m/z 259 (~70%), 244 (20%), 
159 (100%), 158 (45%), 134 (20%). 
2.4.5 Synthesis of 1-methyl-2-guanadinobenzimidazole (28) 
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H2N
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N
N
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H2N
tBuOK,
18-crown-6;
MeI1a 28  
Figure 2.12 Synthesis of 1-methyl-2-guanadinobenzimidazole (28) 
1-Methyl-2-guanadinobenzimidazole, 28 was synthesized from 2-
guanidino-benzimidazole (1a), with methyl iodide as an electrophile 1.63 g (9.30 
mmol) 1a, 1.04 g potassium tert-butoxide (9.27 mmol) and 0.172 g (0.651 mmol) 
18-crown-6 was dissolved in 40 mL THF. This solution was chilled to the 
temperature of melting ice. Methyl iodide (0.580mL, 9.30mmol) was added drop 
wise and the reaction was allowed to rise to room temperature. After 5-10 
minutes a white precipitate had formed. The volume of the THF was reduced and 
the material was neutralized with 1 M NaHCO3. The organic layer was then 
extracted with CH2Cl2 and H2O 3 times. An amount of 0.94 g (5.0 mmol) 1-
methyl-2-guanadinobenzimidazole product was purified by crystallization from 
ethyl acetate and hexane (53% yield). Spectral properties of the product were 
identical to those previously reported in the literature.1,7 
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Chapter 3  
Design, synthesis, and evaluation of an oligomeric 
helical receptor 
This chapter focuses on the design of a conformational motif for molecular 
recognition of anions. Synthetic challenges were encountered in the work so the 
experimental progress was limited. However, much of the iterative design hinged 
on sound experimental results.  
H
N
HN
O
29   
Figure 3.1 Oligourea receptor 
3.1 Introduction 
Hypothetical oligomer 29 should possesses repetitive conformational 
motifs capable of switching between inter and intramolecular hydrogen bonding. 
Molecular modeling studies showed that these oligomers had a high propensity 
to form multiple cooperative hydrogen bonds, and a helix was the most favored 
conformation. Furthermore, the helical conformation, should be stabilized relative 
to other conformers in the presence of anionic species. A differentially protected 
dimer of 29, n=2, showed a very organized pattern of self-aggregation in the solid 
state by x-ray diffraction. Using the dimer of 29 and extrapolating to n-mers in 
PROHFXODUPHFKDQLFVFDOFXODWLRQVSURYRNHVWKHQRWLRQWKDW-sheet-like 
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aggregation will be a low energy conformer of this material. When the dimer of 29 
was extended to n>7, a material was formed which was similar in the structure to 
a -sheet. In the extended dimer, multiple intramolecular hydrogen bonds were 
formed between the two oligomers. This creates an organized aggregation 
pattern, creating a material, that is much less soluble in solution than the 
monomeric units. 
 
Figure 3.2 Hypothetical octamer structure 29, n=8 and a stereo diagram of 
the calculated interaction between 29, n=8 and HPO 42-. 
Enantiomerically pure C2 symmetric 1,2-diamines were used in attempts to 
construct the chain of oligomers. The 1,2-diamines possess C2 symmetry as the 
only point group operation. The same is true for the helix. Helical symmetry 
should result when an anion is present to bind to the oligomer (see figure 3.2).  
Multiple hydrogen bonds could form with the multiple hydrogen bond acceptors 
on the oxoanion. This structure would fold with a helical bias like natural proteins. 
Another positive aspect to using C2 symmetric subunits is the simplicity of the 
construction. Synthesis should be based on N-C amide bond formation. The 
constituent 1,2-diamines due to the C2 symmetry avail both nitrogen atoms as 
nucleophiles. If either one reacts the same chiral product is obtained. The work 
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began with commercially available 1,2-diaminocyclohexane, however the work 
will continue with synthetically available 1,2-diaryl-1,2-diaminoethanes and other 
C2 symmetric diamines. Another graduate student will continue this project in our 
labs. 
In this work we sought to perturb the conformation of the oligomers by 
changing the media and introducing guest anions. The preferred method of 
detection of these conformational changes was CD spectroscopy. CD can be 
used to monitor the conformation of biopolymers in solution.1 Bands in the CD 
spectrum at 190 and 220 nm that correspond to the λmax of the amide carbonyl of 
an α-helix.1 These peaks are mostly independent of the amino acid composition. 
Given this, a similar change would be expected from a secondary structure 
formation in oligomers of 29. The sensitivity of this oligomer to changes in anion 
concentration as well as its own propensity to form a conformation analogous to 
a β-sheet should be investigated. 
In the analysis of the CD results, the goal of molecular modeling 
computation was to relate observed changes upon the titration of the oligomers 
with anions to conformational changes that cause the observable.  α-helix gives 
3 distinctive peaks at 191, 207 and 221 nm. β-conformation gives two peaks at 
194, and 216 nm.2 The CD spectra for an α-helix is essentially constant from one 
protein to the next, assuming the absence of chromophoric side chains or solvent 
interactions.1 This is the primary reason for the expectation that a conformational 
change will result in an observable change in the CD spectra for polyamides. 
The amide bond and the carbonyl are the primary chromophores that 
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generate CD signals. In the α-helix there are two transitions, which are aligned, 
parallel and perpendicular to the screw axis of the helix. This generates the two 
transitions at higher wavelength. Titration caused a change in the CD and NMR 
spectra for both pentamers. For extended oligomers of 29 the material was 
expected to form helices, which should increase the R-value, or the rotation of 
light in one direction per mole of oligomer, for that oligomer. CD titration data was 
more complicated than this, so further investigation of the bound and the 
unbound structures was needed. 
3.2 Biomimetics 
Oligomers of 29 were synthesized to mimic the conformations of biological 
molecules. Biologically derived molecules show the ability to greatly accelerate 
reactions with a phenomenal specificity, and to tightly and specifically bind to 
large or small molecules. These extreme properties drive chemists to study 
biomolecules to understand and mimic their properties. Biomolecules can 
generate much complementary surface area that is useful in forming pockets to 
catalyze or bind to specific molecules. The architectural diversity that comes from 
α-amino acids is rather remarkable. A diverse array of interesting globular 
structures comes from chains of α-amino acids. RNA, and proteins take 
advantage of conformational motifs that generate stable 3D structures that can 
do interesting chemistry. 
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3.2.1 Design of a biomimetic host 
 
Figure 3.3 Structurally related helical foldamers. 
Foldamer is a term that can be used to describe any polymer that has a 
strong tendency to adopt a general conformation. In general, the conformation is 
repetitive, but not necessarily the sequence.3 In the design of 29, a goal was set 
for a system which would be simple to make, but would still lead to complex 
structures. Modeling of 29 and comparison4,5WRWKHDERYH-peptides, in Figure 
3.3, and the natural proteins led to the notion that 29 would also form helices 
similar to those of proteins. Calculations, of the above systems, predict that they 
are relatively rigid and form tight helices. In Figure 3.2 a hypothetical octomer is 
produced with Monte Carlo simulations. The conditions of the modeling are 
described later in section 3.4.1. The general conditions included the use of the 
Amber* force field and the GB/SA solvent model for water; modeling procedure 
are described in detail in sections 3.4.2, and 3.4.3. The octamer structure was 
not tightly constrained and could form a pocket to nearly encapsulate the 
modeled oxoanions. Monte Carlo simulations showed multiple low energy 
conformers with significant coverage of the phosphate molecule. Changing the 
solvent model from water to chloroform only improved the energy of the binding. 
The polar oligoureas formed weak hydrogen bonds that should collectively work 
to bind the oxoanions. An oligourea appeared well suited for anion recognition. 
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The modeling studies showed encapsulation, via helix formation in Figure 
3.2. The encapsulation was nearly complete with an oligourea only 8 units long. 
Multiple hydrogen bonds formed with the oxoanion allowing the oligourea to 
mimic the normal solvation shell of the oxoanion in a hydrogen bonding solvent. 
Ordering in the binding pocket appeared to improve upon use of a single 
enantiomer of trans-1,2-diaminocyclohexane, implying there could be some 
cooperativity in the helix formation. Oxoanions are more difficult to coax into 
intermolecular association with de novo molecular guest than cations, the size 
and directionality of the solvation shell requires a complex molecule, from a 
design and a synthesis standpoint. Oxoanions also possess large negative free 
energies of hydration, keeping them hydrated instead of in an associated state. 
Foldamers are able to form complex complementary surface area from a 
relatively simple linear chain. Despite the large and negative free energy of 
hydration, many biological foldamers6 are able to bind strongly to oxoanions. 
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3.2.2 Foldamer concept 
 
Figure 3.4 Ramachandran diagrams show the limited conformational space 
in polypeptides. Two state behavior in chiral conformational space results 
from this limited chain entropy. 
Biological systems use the foldamer concept to package genetic 
information in DNA oligomers. In DNA, chemical diversity at the level of the 
primary sequence transmits information. This system compacts, folds the 
information for storage, and allows the information to be read, copied, and 
repaired. As a foldamer, DNA can behave like a homogeneous polymer despite 
the fact that it is composed of four different monomers in a plethora of different 
sequences. Likewise foldamers (α-helices, β-sheets, β-turns, β-barrels, and Ω-
loops) in proteins effectively allow 1D sequences to birth complex, functional 3D 
architectures. Diversity in protein conformation is surprising when one considers 
the limited nature of Ramachandran conformational space in peptides (see 
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Figure 3.4).7 On the other hand, the peptide foldamer may be useful for 
biological architecture only because its conformational space is limited. This may 
be a general statement regarding the dynamic behavior of molecules that fold in 
biologically relevant ways. Limited conformational space appears to be an 
important factor in the formation of the biological foldamer and the suitability of 
the foldamer to strong 2D structure formation, not only in proteins but also in 
RNA.8  
3.2.3 Foldamer models 
These general principles can be applied to the design of non-biological 
oligomers. Biological oligomers are not the only interesting, or biologically 
relevant foldamers other foldamers have been formed from oligoamides 
constructed from β-amino acids or β-peptides.9 The conformation of these 
peptides was studied and compared to the natural α-peptides using the diversity 
inherent in the α-peptide system. Several examples of biological activity and 
therapeutic application of β-peptides have been found. One of Gellman's 
cyclopentane derived β-peptides, β-17 displayed unique antibacterial activity in 
its ability to kill the drug-resistant strains, Enterococcus faecium and 
Staphylococcus aureus.10 The antibiotic activity appears to derive from the fact 
that the β-peptide folds into helix which disposes hydrophobic side chains on one 
side and cationic side chains on the other, similar to a family of antibiotic 
peptides, the magainins. Seebach has also found biological activity in β-
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peptides.11 These materials obviously resemble their natural peptide cousins 
and interact with the body in a manner similar to the α-congeners.  
 
Figure 3.5 Foldamer-based molecular recognition.  
If β-peptides are scientifically interesting,9 other conformationally 
constrained oligomers bearing peptide-like properties should be considered in 
this regard as well. In fact some other non-peptide foldamers have been studied 
and were found to form some unique and interesting 3D forms.12-15 The 
foldamer in Figure 3.5 was synthesized by Moore to demonstrate that foldamers 
could be used to establish cooperative molecular recognition.12-15  Work with 
this foldamer established that this class of materials could be used to form a 
three dimensional cavity, for pocket binding of guest molecules. In these well-
balanced systems, the electronic nature of the internal space, the external 
surface and the solvent molecules differed little. Furthermore, the chiral 
conformation in the foldamer came from the chiral guest. This foldamer differs 
from the ideas involved with the foldamer system 29.  Moore’s foldamer explores 
achiral hydrophobic spaces and chirality is induces in the molecular host by chiral 
guests; see Figure 3.5. In contrast, in the development of foldamer 29, the 
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objective was to achieve a chiral conformational change by binding an achiral 
anion to a chiral foldamer; see Figure 3.2. 
3.2.4 Building a biologically-inspired foldamer 
Enantiomerically pure trans-1,2-diaminoethane units were used as 
building blocks for the synthesis of 29. (1R,2R)-1,2-diaminocyclohexane and 
(1R,2R)-1,2-diamino-1,2-diphenylethane (to be reported elsewhere) were used 
as monomers. The functionality of the monomers was similar to peptides both 
contain sp2 hybridized hydrogen bond donors, the amide or urea NH 
functionality, and hydrogen bond acceptors, the carbonyl oxygen. The material 
was applied to a foldamer-based molecular recognition of oxoanions. Here, the 
local chirality of the monomer, C2, predisposes the chain to take on 
conformations capable of doing molecular recognition. 
In the proposed interactions between an oligourea and biologically 
relevant anions, the urea N-H functionality will point toward the axis of the helix 
and the aliphatic portion of the oligomer will occupy the perimeter of the helix. In 
suitable solvent, the guest will be enveloped by the oligourea. Conformational 
tendency in these oligomers should be controllable. The chiral 1,2-dimino ethane 
derivatives will have a tendency toward helicity, if each unit is either (R,R) or 
(S,S). In this manner, by virtue of its conformation, the oligomer will define the 
physical-chemical nature of inner and outer space. We see this property as 
potentially useful to the development of smart solids for chemo sensors and drug 
delivery of biologically relevant anions.  
71 
The molecular recognition scheme outlined above is biomimetic. The 
proposed conformational bias in the oligomers under consideration involves the 
principle of hydrogen bond cooperativity. This important characteristic of 
biological oligomers consists of numerous weak interactions contributing 
additively to a bioactive conformation.16,17 The establishment of each atomic 
contact between the helix and the guest molecule should contribute 
synergistically to the stability of the ensemble.  
Designed molecular recognition between large, non-biological and 
biological molecules has not received enough attention. Usually investigators 
pursuing molecular recognition target small guests toward small hosts. Likewise, 
the most important targets in the pharmaceutical community fall under the 
category of ‘small molecule drugs.’ Minimally complex molecules work well when 
searching for drug candidates because they are well suited for molecular libraries 
and high throughput screening. However, the majority of life processes involve 
the chemistry of polymers or oligomers. This principle is self-evident when one 
considers the central importance to the organism of materials like DNA, RNA, 
proteins, polypeptides, polyketides, tubulin, collagen, hyaluronan (and other 
oligosacharides) and lipid membranes. A living cell is not a solution of proteins 
and other biological substances; a cell is a gel due to the plethora of interactions 
between biological molecules. Clearly, most biochemical processes and much 
molecular recognition in the biological context occur at interfaces between solid 
and solution. There is much space for scientific thought and molecular design 
72 
between 'small molecule' drugs and the kind of substances that biologists and 
chemists consider oligomers.  
3.3 Synthesis 
A foldamer, 29 was synthesized using the synthetic intermediate (1R)-1-
amino-(2R)-2-isocyanatocyclohexane as a template for the formation of an 
oligourea. Using different protecting and activating groups different oligomers 
were synthesized. Synthetic problems prevented the facile synthesis of 
oligoureas greater than 4 units in length. Long oligoureas were needed to be able 
to form a helix around the oxoanion. This conformational change would result in 
a detectable changes in the circular dichroism spectra of the complex. To 
overcome these problems, isophthalic acid, and 1,3-phenylenediisocyanate were 
used as spacers to increase the chain length. Amine protection with Boc 
anhydride and ethyl trifluoroacetate was used to control reactivity at either end of 
the molecule to enable effective elongation of the oligomers. Isophthalic acid was 
mono protected as the methyl ester. Convergent syntheses after each major step 
should have led to new binding candidates. 
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Figure 3.6 Synthesis of a differentially protected dimer. 
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Figure 3.7 Crystal Structure of 33 
Trans-1,2-Diaminocyclohexane was dimerized by adding 1-
trifluoroacetamido-2-aminocyclohexane 32, slowly to a solution of triphosgene, 
converting the unprotected amine into an isocyanate. This isocyanate reacted in 
a facile manner with 31 when the amine was added quickly to the isocyanate of 
32. This material could be crystallized from methanol/ethyl acetate in 60% yield. 
The crystal structure is shown above in Figure 3.7. The differentially protected 
dimer, 33, could then be quantitatively differentially deprotected with the use of a 
20% v/v solution of TFA/CH2Cl2 for removal of the t-Boc protective group and 0.2 
N barium hydroxide in 50% aq. methanol for removal of the trifluoroacetamide 
protective group. Deprotection of the trifluoroacetamide protection group gave a 
chloroform soluble amine, 35, which was used to proceed further in the 
synthesis. 
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Figure 3.8 Synthesis of protected pentamers with spacers 
Spacers were employed to make pentamers 39, and 44 after the 
heterocoupling of 34, and 35 with triphosgene did not result in a well-defined 
chemical species 60 (see Figure 3.9). Dimer 33 and pentamers 39, and 44 gave 
well-defined 1H, 13C, and MALDI-TOF spectra. 34 reacted in a facile manner with 
isophthaloyl chloride to form pentamer 39 in good yield. 31 was also reacted with 
isophthaloyl chloride, and 32 condensed with 1,3-phenylenediisocyanate in good 
yield to form their respective trimers. 
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Figure 3.9 Synthesis of differentially protected oligomers 
The methyl ester 37 was easily deprotected with 4 equivalents of lithium 
hydroxide, converted to the acid chloride and reacted with the trifluoroacetamide 
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protected dimer, 34, forming a differentially protected pentamer. Unfortunately, 
this material was not well defined by MALDI-TOF, despite the fact that the 
symmetrically protected pentamer 39 above was well defined. NMR of 59 had 8 
amide type NH peaks, but purification of the material by flash chromatography 
gave a material which was similar to 35. 
Hetero-protected oligourea 60 was not obtained by using triphosgene or 
carbonyldiimidazole coupling regents. Current work on the synthesis of these 
oligomers is currently being done by others in the group. This work is briefly 
discussed in the addendum.  Carbonyldiimidazole produced only dimerized 
product and was ineffective at producing a heterocoupled product.  Triphosgene 
was also ineffective at producing a heterocoupled product due to the low 
solubility of Tfa-protected dimer 34. A protected diamine has been synthesized 
activated and isolated using p-nitrophenyl-chloro-formate as an activating 
reagent. 
The sensitivity of the conformations of free amine derivatives 40 and 45 to 
the concentration of PO4 were compared to those of shorter derivatives 43 and 
38b (Figure 3.26). These studies should have evaluated the ability of dimer 33 to 
function as substructural units in the molecular recognition of oxo-anions. The 
linkers were long enough to allow the two ends of the oligomer to meet in 
modeling studies, and should be more effective than a simple homocoupled 
oligourea from a dimerizing activating agent like carbonyl diimidazole. 
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3.4 Computation and modeling 
Computation was used in the design and analysis phases of this research. 
Modeling directed the synthesis toward oligoureas that were helical in the 
presence of phosphate (see Figure 3.2). Modeling also sought to investigate the 
possible two-state behavior of the oligoureas. 
3.4.1 Monte Carlo simulations 
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Figure 3.10 Monte Carlo simulation of the low energy structure pentamer 40 
with HPO 42-  
Monte Carlo simulations done on 200 trial conformations of 40, 
procedures, and theoretical details as described below, found 12 low energy 
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conformations within 3 kcal/mol of the lowest energy structure shown above in 
Figure 3.10. Variations between the low energy conformers, found by the Monte 
Carlo search routine, of phosphate-bound pentamer were small. Structures 
lacked the length to wrap the phosphate in a helix, which would require the 
oligomer to wrap greater than 360° around the phosphate. 40 formed an 
interesting cup like structure in which the pentamer wrapped the phosphate, and 
the phenyl ring held the phosphate in the cup. Other conformers moved the 
position of the phosphate in the cup, or moved the amine of the terminal 
cyclohexane ring in or out of the cup. 
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Figure 3.11 Pentamers 45, 40 with solvent exposed surface (1.4 Å probe 
radius) 
78 
 
Figure 3.12 Description of conformational searching with Monte Carlo 
simulations 
One of the primary goals of molecular modeling is to find the global 
minimum structure for any given oligomer. Unfortunately, because of the way that 
modeling programs find energy minima, the structure that results may not be the 
lowest energy conformation for the molecule. The lowest energy conformation 
given by the minimization can be referred to as the global minimum. The global 
minimum shown in the above figure is the deepest energy well. Local minima, 
shown above, as the smaller wells can also be important for chemical reactivity 
and, if the barriers to the interchange between the different conformational 
isomers are low, then the molecule may spend part of its time in one or more 
local minima. 
Monte Carlo simulations explore the dynamics of the molecule. Most 
minimization programs calculate a derivative of the energy at a particular 
conformation. The conformational variables are then adjusted based on that 
derivative. This allows for fast determination of minima. Using this technique local 
minima are found if starting from a or b in conformational space or the global 
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minimum if starting from c. Users of modeling software defeat the predisposition 
to achieve local minima by intelligent choices of starting points. Monte Carlo 
simulations attempt to simulate heat energy to explore the dynamics of the 
molecule. A Monte Carlo simulation18 takes a set of rotatable bonds and applies 
a random change, such as a rotational increment between 0 and 360°, or an 
atom displacement. If there are no high-energy steric interactions, then a 
minimization is run, and the energy compared to the lowest previously found 
minima. If a minimum structure is found then this is the new starting point and 
this structure is adjusted. Otherwise, the Metropolis algorithm19 is used to 
determine if the trial configuration is accepted as the new starting point.20 This 
algorithm generates a random number between 0 and 1, then compares this to a 
probability given by the Boltzmann distribution. exp(-∆Ei/kT) If the random 
number is smaller, then the new conformation is accepted as the new starting 
point. 
 
Figure 3.13 Pentamer 40, 45 with arrows to indicate the dihedral angles 
simulated in Monte Carlo calculations 
Monte Carlo simulations ran trial configurations of pentamers 40, and 45 
with the Amber* force field, and the chloroform solvent parameter set. 
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Calculations set to find all conformations within 50 kJ/mol of the found global 
minimum. Pentamer minimizations calculated in a fashion similar to those of the 
Ramachandran plots shown below. Monte Carlo simulations ran with the 
constraints for torsinons marked with curved arrows, seen in Figure 4.13 above 
to reduce multiple high energy conformers and reduce the time required to find 
low energy conformers. 
3.4.3 AMBER* 
The AMBER* torsional parameterization set was employed with the 
program Macromodel Interactive Molecular Modeling System Version 5.0® to 
determine the low energy conformation of the oligomers. Amber is a molecular 
mechanics force field that is widely used for modeling biological oligomers. Like 
most molecular mechanics force fields this one is quite dependent on 
experimentally determined variables. Stability is conferred to the molecule if it 
can come close to the optimal bond length, bond angle and dihedral angle. A 12-
6 parameter set is used to mimic the effects of the van der Waals forces. The 
sum of these effects gives an overall energy for the conformation of the 
molecule. This and other improvements in the parameters for the peptide 
backbone allow for optimal results for peptides. 
3.4.4 Solvation treatment 
Solvent can have a major affect upon the relative energy of many 
substances. Macromodel uses the GB/SA model to describe the effects of 
solvent. A chloroform parameter set was used for the analysis of oligomers of 29. 
The free energy associated with solvent, Gsol, is the sum of three terms,21 
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including a solvent-solvent cavity term, Gcav, a solute-solvent cavity term, GvdW, 
and a solute-solvent polarization term, Gpol (Gsol = Gcav + GvdW + Gpol). For 
saturated hydrocarbons Gsol is linearly related22,23 to the solvent accessible 
surface area (SA). Gcav and GvdW can be calculated by a determination of the 
solvent accessible surface area and the solvation parameter for each atom. The 
other parameter modifies the electrostatic attraction of a system of widely 
separated charges. The generalized Born equation21 relates the dielectric 
constant of the solvent to a contraction of the attractive or repulsive forces of 
separate charges. An article21 by Still and Thompson describes well the 
generalized Born equation and its relation to Gpol. 3.6.11 Molecular modeling of 
oligomers (29) 
Oligomers were modeled using MacroModel,24 a molecular mechanics 
program to find optimum (minimum energy) conformations. Molecular mechanics 
uses sets of force fields that have been optimized using experimentally, and ab 
initio determined molecular constants. Molecular modeling is primarily used to 
examine molecules that are large of have many degrees of freedom that make 
them difficult to minimize using more computationally intensive methods. A force 
constant is used to put an energy value to torsion and bond length parameters. 
Molecular mechanics also uses experimentally determined values for the van der 
Waals radii and electrostatic attractions are also used to determine the low 
energy structure. 
Monte Carlo simulations were run with unbound pentamers 40 and 45. 
Simulations gave the conformational energy minima shown by the conformers in 
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Figure 3.11 above. These structures had varying degrees of compactness and 
helicity. Pentamer 45 appeared to be more stable in the most compact forms. 
Pentamer 40 appeared to be more stable in less compact conformations. In 
pentamer 45, each dimer arm is conformationally stabilized with a 7-membered 
ring formed between the amide NH of one urea and the carbonyl CO of another. 
40 was not as globular in its minimum energy conformation, and the two dimer 
arms crossed each other at a higher angle than that of 45. See below for a 
diagram of the difference between 45 and 40, in Figure 3.14. The change in the 
angle of the two dimer arms and the chain length caused by the change from an 
amide to an urea around the phenyl ring caused the molecule to go from a tight 
ball to a molecule that looks like a set of arms crossed.  
 
Figure 3.14 Diagram of position of cyclohexane arms in the pentamer 40 
and 45 
Like the biological molecules, the change in the dynamic globular structure 
of the two pentamer bodes a change in the rotation of circularly polarized light. 
Despite the small size of the molecules, they do appear to have a definite 
conformational preference. The ball shaped conformation of structure 40 
83 
appeared to have little effect on rotationally polarized light, but the crossed arms 
of the conformation of pentamer 45 had a larger effect. 
3.4.5 Conformational motifs and predictions of two-state behavior 
Ramachandran plots, like the one shown in figure 3.4, indicate 
conformational propensity in complex conformational space as a function of two 
rotatable bonds. Limiting the conformational space is very important to biological 
molecules. This limited conformational space governs the ability of biomolecules 
to adopt native (functional) or extended (denatured) states. Using this type of plot 
Ramachandran and coworkers7 defined an upper limit on the conformational 
space of peptides. Ramachandran defined the atoms in his dipeptide as spheres 
that have a hard shell and are not allowed to penetrate the shell of another atom. 
If a conformation causes two atoms’ shells to penetrate then the conformations is 
not allowed. Large portions of the map are excluded using this method, but the 
sections that are not excluded can be used to categorize the various folding 
patterns in peptides.  It is also possible to use the chart to predict if certain 
folding patterns are or are not allowed. The plot predicts the common right-
handed α−helix, shown in the bottom left hand corner of the plot in Figure 3.4, as 
an allowed structure. The not so common left-handed helix, in the small lightly 
gray patch in the upper right-hand corner was predicted as an allowed but rare 
structure. The gamma helix lies outside the outer limit for the minimum contact 
distance and therefore is not allowed. The extended or β-structure labeled part of 
the plot in allowed conformational space for the dipeptide. It is difficult to see in 
the plot in Figure 3.4 but the α-helix has a deeper well (more stable) than the β-
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structure. However, the β-structure covers more area in conformational space. 
Therefore, the β-structure should be entropically favored and thus favored at 
higher temperatures. Basically this gives rise to the two state behavior of peptide 
and protein folding. 
Peptides that are longer than two amino acids in length have long-range 
steric interactions.25 The long-range interactions of larger peptides impose 
further restrictions on the motion of the peptide. The packing of the chains of 29 
should increase the order of the molecule with increasing length. The 
Ramachandran plot data for 56 showed a conformational preference for one of 
the four energy wells, and changing the solvent increases this preference. 
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Figure 3.15 Ramachandran plot of the rotation of  Φ1 and Φ2 in structure 56 
using the GB/SA chloroform parameter set. 
86 
 
 
Figure 3.16 Ramachandran plot of the rotation of Φ1 and Φ2 in structure 56 
using the GB/SA water parameter set. 
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Figure 3.17 Ramachandran plot of the rotation of Φ1 and Φ2 in structure 56 
+ 2HCl using the GB/SA water parameter set. 
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Figure 3.18 Low energy intermediate 
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Ramachandran plots of the dimer 56 showed the effects of conformation 
and solvent upon the hydrogen bond strength. Figure 3.16 showed that 
chloroform increases the effect of the intramolecular hydrogen bond on molecular 
conformation. In Figure 3.16 some of the energy wells are much deeper than 
others. The conformations correspond to the establishment of hydrogen bond 
donors and acceptors. The conformation shown in Figure 3.19 was one of the 
common energy wells shown in the RC plots. The seven member ring 
constrained by a hydrogen bond is also found in some of the high energy 
intermediates, presumably due to high energy atom contacts from the proton and 
nitrogen which are pushed too close to the amide NH. In Figure 3.16 and 3.17, 
the RC plots showed a decreased influence of the intramolecular hydrogen bond 
due to the solvent change from chloroform to water on the molecular 
conformation. The molecule can more easily explore four different regions of 
conformational space in water. Conformation appeared to be controlled primarily 
by the steric arguments. 
Folding in apolar solvents appears more promising, and some helix 
inducing alcohols like trifluoroethanol or hexafluoroisopropanol may induce these 
conformational changes in mostly aqueous solvents.26-28 The RC plot of the 
dimer in chloroform solvent gave low energy conformations in a smaller portion of 
the chart, with higher barriers between different energy wells. Some of the 
regions in the chart were explored with molecular modeling to identify forms that 
will come from them. The α−UHJLRQDQGWKH-regions of the chart were indicated 
in Figure 3.17. The determination of α- versus β-regions was determined by the 
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analysis of the compounds modeled from the crystal structure of the dimer 33. 
Regardless, the Ramachandran space characteristic of the dimeric oligourea hint 
that conformational motifs reminiscent of natural polypeptide chains should be 
possible for the planned oligomers. The hypothetical structures below were 
modeled and the dihedral angles of the resulting structures were sampled. 
 
To find the Ramachandran plot for a dimer of the oligomer 29, 56 was 
minimized and the two dihedral angles for the two CN bonds immediately 
adjacent to the urea, φ1, and φ2 were adjusted. First φ1 then φ2 is rotated from 0° 
to 360° in increments of 10° to make 1296 energy measurements. Energy is 
determined for each conformation, and the data can be plotted on a contour plot 
like that of the well-known Ramachandran plot for φ, and ψ in proteins. 
3.4.6 Protein like conformations of oligourea (29) n=8 
 
Figure 3.19 Extended dimer crystal structure 
Modeling of oligourea 29 showed the propensity of the molecules to mimic 
prRWHLQIRUPV2IWKHVHIRUPVWKH-sheet seems most obvious. The protected 
dimer formed a thick gel when added to halogenated solvent with a small percent 
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DOFRKRO7KHVWUXFWXUHLQ)LJXUHVKRZVDVWDEOH-sheet like structure found 
for 29 n=8. This structure came from another modeling study. Two adjacent 
molecules of 33 from the crystal structure shown in Figure 3.7 were deprotected 
and elongated to eight units in length. They were then modeled with an Amber* 
force field, and water was modeled by the GB/SA solvent parameters. The 
UHVXOWLQJFRQIRUPDWLRQRIVWUXFWXUHVUHVHPEOHGDVHWRI-sheets in the way they 
formed a short network of perpendicular hydrogen bonds. The resulting 
aggregate was highly stable and could form a gel in solution. Urea compounds 
often form gels in solution. These gels may mimic the protein-protein interactions 
of the cellular environment. 
 
Figure 3.20 Hexadecamer helix conformer 
Figure 3.21 shows a helical conformer of 29 n=8 with the right hand end 
acetylated. The above structure was a highly favorable conformer found through 
molecular modeling, which was lower in energy than the β conformation shown in 
Figure 3.20. Rotating the CN bonds so that NH bonds made contact with unit 
N+1 formed the α-structure. A minimization was then carried out using the same 
parameters as the β conformer, resulting in the conformation shown in Figure 
3.21. 
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3.5 Evaluation and conclusions 
3.5.1 CD titrations 
In the modeling phase of this experiment it was hypothesized that upon 
addition of significant amounts of oxoanion, oligomers would bind and cause a 
gross change in the circular dichroism spectrum. CD spectroscopy required a low 
concentration of the oligomer for analytical determination of the CD spectra. To 
test the binding of the pentamer to phosphate an organic soluble source of 
phosphate was required. The tetrabutyl ammonium dihydrogen phosphate salt 
was an excellent source for solvents from methanol to acetonitrile to chloroform. 
Although the oligomers were modeled in a chloroform solvent field, that solvent 
was not transparent to UV light at wavelengths of less than 240 nm. The window 
of wavelengths in which urea absorbs is 200 to 240 nm; therefore this is the the 
region where we would like to detect the CD spectra. Acetonitrile is transparent 
for this section of the UV spectrum, so it was used for this titration. Titration 
methodology to detect binding of deprotected pentamers 40, and 45 is described 
later in section 3.5.2. 
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Figure 3.21 CD titration of the pentamer 45. 
There appeared to be two different binding constants for pentamer, 45, 
detectable in acetonitrile. The first appeared around 0.02 mM, phosphate and the 
second around 0.2 mM. The concentration was ~0.01 M pentamer. In water with 
Na2PO4, this pentamer had no detectable change in its CD signature. Binding for 
this molecule seemed improbable in water, but comparison to the amide 
pentamer augmented the argument that binding was present in acetonitrile. 
Titration had significant drift due to error in the measurement of CD spectra. Error 
bars are included in Figures 3.22 and 3.23 for CD measurements in the titration 
of amide pentamer 45 and 40. Error was calculated for each measurement, and 
appears in graph to ± 2 standard deviations. Each data point was measured 
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three times and the standard error calculation was made for determination of the 
error. This titration was repeated 2X with both shown on the graph below. 
 
Figure 3.22 CD titration of pentamer (40) . 
Pentamer 40 was titrated under the same conditions as pentamer 45, but 
gave a greater CD response. The response for 40 was enhanced for the second 
binding constant by a precipitation phenomenon that did not occur for 45. The 
binding constant for pentamer 40 was similar for similar concentrations of 
oligomer and phosphate versus those for pentamer 45. The first and second 
binding constants occurred at 0.02 mM and 0.2 mM. Error bars for CD data of 
pentamer 40 are similar in absolute value to those for 45.  
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Figure 3.23 Jobs plot for amide pentamer (40). 
Jobs plots are useful tools to determine the stoichiometry of binding for a 
particular binding curve. In the Job’s plot the total concentration of the host and 
the guest are not varied, but the ratio between the two is. The ratio with the 
maximum observable is the stoichiometric ratio for the binding constant of 
interest. In the above Jobs plot, the maximum observable occurred at a ratio of 
0.5/0.5 H2PO4/pentamer. Therefore, the binding constant of 0.02 mM 
corresponds to a 1: 1 binding stoichiometry of phosphate to pentamer. 
Binding stoichiometry for pentamers appeared to vary between the two 
concentration regions in the two titration plots. The binding constant was similar 
for 45 and 40, so there is no reason to believe there is variation between the two 
pentamers. Jobs plot data for pentamer 40 were collected at concentrations 
between 0.02 and 0.08 mM pentamer. Total concentration of the anion and the 
pentamer was kept constant at 0.1 mM. This range of concentrations puts the 
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titration after the endpoint of the first binding constant and before the midpoint of 
the second binding constant. This implies that the first binding constant was the 
predominant factor in the determination for the Jobs plot stoichiometry. 
3.5.2 Experimental method for determination of the binding of C 2 symmetric 
hosts, 40 and 45, to phosphate by circular dichroism spectrometry. 
Pentamer 40 (3.0 mg, 4.7 µmol) was dissolved in 50 mL of a 1/49 mixture 
of methanol/acetonitrile to give a 9.5x10-5 M solution of 40. This was solution A. 
Another solution consisted of tetrabutylammonium dihydrogenphosphate (39.1 
mg, 115 mmol) in 100 mL of a 1/49 mixture of methanol/acetonitrile, respectively, 
to give a 1.2x10-3 M solution of phosphate. This was solution B. The phosphate 
solution B was added to ALQZLWKDQDXWRSLSHWWHLQ/LQFUHPHQWV6ROXWLRQZDV
mixed in the CD cuvette. CD spectra for the solution in this cuvette were scanned 
2x between 250 and 200 nm and recorded. Data was monitored along the peaks 
for both pentamers. Nitrogen was flowing though the spectrometer at a rate of 
20-30 mL/minute. A standard error calculation of  
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= −
−
=
N
i
i
N
xx
s
1
2
1
)(
 
was used to calculate the error in three measurements of CD data. Another 
titration was done but at different concentrations of phosphate so was not 
included in the calculation. Individual error calculations were done on each point 
in the other titration.  
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3.5.3 NMR titration of oligomers 
 
Figure 3.24 NMR titration of oligomers with NaH 2PO4, monitoring the protic 
ammonium peak  
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Figure 3.25 Oligomers tested for binding to phosphate by NMR methods 
NMR titration of the oligomers verified the binding constants obtained 
through CD titration methods. Four oligomers (38b, 40, 43, and 45) tested 
positive for binding to phosphate by NMR methods. The change in the NH peak 
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height and subsequent disappearance of that peak indicated a change in the 
chemical shift of the peak. The peak was not detected elsewhere, but evidence 
indicated that the peak should be found near the water peak and therefore 
undetectable. The NH peak of interest was the R-NH3
+ peak for the oligomers. 
The peak was a single broad peak as a result of fast H+ exchange that comes 
with the acidity of the ammonium protons. Amide and urea protons were slightly 
broadened doublets. Before the titration, the ammonium peak was approximately 
1.5-fold the size of the peaks corresponding to the amide and urea protons. This 
was the expected ratio of protons derived from the structure. 
Changes in solvent structure explained the up-field movement of the NH 
peak. The ammonium protons were solvated in solution by multiple water 
molecules. Upon binding to phosphate, the water structure was broken and fewer 
electron-withdrawing hydrogen bonds could form to the oligomer. A more 
electron-rich proton resulted from this change in solvent structure, and therefore 
the chemical shift of the proton moves up-field. 
The three oligomers, included above in Figure 3.26, have one similar 
binding constant between 12 and 17 mM. The two urea oligomers 40, and 43 
share another binding constant at 3 mM. The data set for 38b indicated a 
binding constant similar to those for the other three oligomers tested. Variability 
in the data made the results inconclusive. 
The urea pentamer, 45, and trimer, 43, precipitated in solution, but 
concentrations remained high enough to determine peak integrations. The 
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internal reference for the NH proton integration was a phenyl CH proton. 
Therefore, the precipitation did not bias the results.  
3.5.4 Experimental method for the determination of the binding of C 2 
symmetric hosts, 40 and 45, to phosphate by 1H NMR. 
Two solutions were prepared for this determination. For solution A, 11.7 
mg of free amine 40 was dissolved in 0.04 mL 1 N HCl, 0.49 mL H20 and 1.1 mL 
methanol-d4. This solution was 71% 
1H, 29% 2H for the exchangeable protons, 
so amides should appear at 71% of the expected height for a solution in an 
aprotic NMR solvent. For solution B, 28.0 mg of NaH2PO4 was dissolved in 0.53 
mL of H2O and 1.1 mL methanol-d4. The concentration of sodium dihydrogen 
phosphate was 146 mM. Solution B was added to solution A and the proton 
NMR spectra was acquired under presaturation conditions. The 90° pulse width 
was determined for the solvent mixture, and saturation delay time was optimized. 
Aliquots of solution B were added to the NMR sample and shaken. The NMR 
was shimmed after each change in phosphate molarity. Peaks at chemical shifts 
7.8, and 8.3 were integrated and the ratio of the two peaks changed of changing 
concentrations of NaH2PO4. The ratio of the integrations of the two peaks was 
monitored over the course of the titration. Care was taken in order to make the 
integrations consistent over the course of the titration. 
The above titration was repeated for pentamer 45. The solvent conditions 
of solution A were matched for solution C, which contained 8.3 mg (12.4 µmol) of 
45 in 0.028 mL of 1 M HCl, 0.340 mL of DI water and 0.742 mL of methanol-d4 
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for a total of 1.11 mL solution of 11.2 mM concentration. Solution B was also 
used for this titration. Peaks at 6.0 and 7.8 were used to monitor the titration. 
3.6 Synthetic procedures and data 
3.6.1 (1R, 2R)-1-(N-t-butyloxycarbonylamino)-2-aminocyclohexane (31) 29 
NH2
NH2
NH2
NHBoc
BocOBoc
CHCl3
30 31  
Figure 3.26 (1R, 2R)-1-( N-t-butyloxycarbonylamino)-2-aminocyclohexane 
(31) 
 (1R, 2R)-(+)-trans-1,2-diaminocyclcohexane, 30, was resolved to optically 
pure (R,R) or (S,S) by a literature procedure.30 The optically pure diamine is also 
available commercially, but expense prohibits buying this material in bulk. To a 
cooled solution of 30 (3.36 g, 29.5 mmol) in CH2Cl2 (100 mL) was added a 
solution of Boc anhydride (3.0 g, 13.7 mmol) in CH2Cl2 (100 mL) slowly over a 
period of 4h. The reaction mixture stirred overnight at RT. Water (25 mL) was 
added in order to dissolve the precipitate. After separation, the organic phase 
was concentrated under reduced pressure and the residue dissolved in ethyl 
acetate (25 mL). Water (25 mL) was added, the mixture was acidified to pH=5 
with 2N HCl and the bis-protected diamine was extracted with ethyl acetate (2 x 
20 mL). The aqueous phase was adjusted to pH=10 with NaOH and extracted it 
into ethyl acetate (3 x 20 mL). The combined organic layer was dried (Na2SO4) 
and evaporated under reduced pressure to yield 31 (1.87g, 8.72 mmol, 30% 
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based on the starting diamine). Spectral properties of the product were identical 
to those previously reported in the literature.29 
3.6.2 Synthesis of N-(2-amino-cyclohexyl)-2,2,2-trifluoroacetamide (32) 31 
NH2
NH2
NH2
NHTfa
EtOTfa
CHCl3
30 32  
Figure 3.27 Synthesis of N-(2-amino-cyclohexyl)-2,2,2-trifluoroacetamide 
(32) 
To a cooled solution of (1R, 2R)-(+)-trans-1,2-diaminocyclcohexane (2.0g, 
17.5 mmol) in CH2Cl2 (100 mL) was added a solution of ethyl trifluoroacetate 
(0.94 mL, 7.97 mmol) in CH2Cl2 (50 mL) very slowly over a period of 4h. The 
reaction mixture stirred overnight at RT. Water (25 mL) was added and after 
separation, the organic phase was concentrated under reduced pressure and the 
residue dissolved in ethyl acetate (25 mL) and water (25 mL). The mixture was 
acidified to pH 5 with 2N HCl, and the bis-protected diamine was extracted with 
ethyl acetate (2 x 20 mL). The aqueous phase was adjusted to pH ~9 with 
Na2CO3 and extracted it into ethyl acetate (3 x 20 mL). The combined organic 
layer was dried (Na2SO4) and on evaporation a white solid 32 as a white solid 
(0.87g, 4.14 mmol, 24% based on the starting diamine). 
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3.6.3 Synthesis of dimer (33) 
NHTfa
NH2
NHBoc
NH2
NHTfa
H
N
H
N
O
NHBoc
32
33
2. NEt3,
1. Triphosgene, NEt3
31
 
Figure 3.28. Dimer forming reaction  
 (1R)-1-triflouroacetamido-(2R)-2-aminocyclohexane (2.04 g, 9.71mmol) 
was dissolved in 40 mL CHCl3, 6 mL acetonitrile, and 3 mL triethylamine. This 
solution was added to a solution of triphosgene (1.05 g, 3.53 mmol) in 14 mL 
CHCl3 at a rate of 20 mL/h for the first two hours and 30 mL/h for the second 
hour. During the addition the reaction was kept at a temperature of 15 to 20 Û&E\
the addition of small amounts of ice into a large ice bath. After addition was 
complete the reaction was stirred for an additional 20 min The (1R)-1-
butoxycarbamate-(2R)-2-aminocyclohexane (2.08 g, 9.70 mmol) was dissolved in 
12 mL CHCl3 and 2.2 mL triethylamine. This solution was added quickly in one 
portion to the reaction to the previous reaction. The reaction was allowed to stir 
overnight, and worked up with 2.0 mL methanol. The remaining CHCl3 was 
removed with a stream of nitrogen. Trifluoroacetamide 32 and butoxycarbamate 
31 protected diamines were removed by 3 extractions with a 10/15 solution of 
saturated ammonium chloride and distilled water. Then basified with aqueous 
sodium carbonate. The resulting organic layer was purified by crystallization from 
ethyl acetate and methanol. The resulting crystals were thin needles that partially 
102 
melted and turned brown at 241-242 °C. Subsequent crystallizations from the 
same mother liquor also gave crystals of good purity.  
1H-NMR (400 MHz; CDCl3) δ 8.32 (1H, d), +G +G
(1H, b) 3.62 (1H, m), 3.42 (1H, m), 3.35 (1H, m), 3.26 (1H, m), 2.22 (1H, d), 1.95 
(2H, t), 1.82 (1H, d), +P+V-1.4 (8H, m). 13C-NMR (100.4 
MHz; CDCl3 + 3 drops CD3OD) δ 159.3, 157.6 (q, J=37.4 Hz), 156.9, 115.9 (q, 
J=287 Hz), 79.3, 56.5, 54.3, 54.1, 51.8, 32.9, 32.6, 32,3, 31.1, 28.2, 24.9, 24.8, 
24.7, 24.2. MALDI (MNa+) 473 (M-Boc+2H) 351. Anal. Calcd. For C20H33F3N4O4 
C, 53.32; H, 7.38; N, 12.44 found C, 53.15, H, 7.27, N, 12.32. IR: 3320.7(s), 
3276.1(m), 2940.6(s), 2856.4(m), 1700(s), 1685.1(m), 1639.7(s), 1450.3(w), 
1367.2(w), 1322.6(m), 1276.2(w), 1253.1(w), 1181.6(s) 
3.6.4 Synthesis of amide (37) 
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Figure 3.29 Synthesis a differentially protected oligomer. 
To make the mono-deprotected dimer 35 the di-protected dimer 33 
(0.6946 g, 1.542 mmol) was refluxed for 2 h in 10 mL of 1 M LiOMe in MeOH 
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with 10% distilled water, and then evaporated under vacuum. The residue was 
then dissolved with heating in EtOAc and distilled water. The aqueous layer was 
removed and the organic was acidified with saturated NH4Cl. The organic layer 
was extracted 6X with saturated NH4Cl. The combined aqueous layers were 
basified with Na2CO3 (aq.) to pH 10. Extraction was done with EtOAc 3X. 35 was 
obtained clean and was used as obtained in the next step (365.5 mg, 1.031 
mmol, 67%). 
Methyl,hydrogen isophthalate (50.0 mg, 0.278 mmol), prepared from the 
dimethyl ester by a literature method32, was stirred in 5 mL distilled CHCl3 and 
80 µL of oxalylchloride. N2 was allowed to flow over the reaction. Upon addition 
of two drops of DMF, gas evolved from the reaction, and within 10 min the 
reaction was complete. This reaction was evaporated under vacuum and 
restored to normal pressure under N2.  
To the acid chloride a solution of amine 35 (92.1 mg, 0.260 mmol), NEt3 
(280 µL) was added drop wise at 0Û&7KHUHDFWLRQZDVVWLUUHGIRUKDQGGLOXWHG
with 5 mL CHCl3, and worked up with 2.5 mL portions of NaHCO3, and distilled 
water. Product was crystallized from MeOH, EtOAc, and hexane. Crude material 
was dissolved in MeOH, diluted with EtOAc, and precipitated with hexane, gave 
54.7 mg (0.106 mmol, 41%) of clean amide 37. 
1H-NMR (400 MHz; CDCl3) δ 8.48 (1H, dt), 8.15 (1H, dt), 8.03 (1H, dt), 
7.56 (1H, td), 3.70 (1H, m), 3.60 (1H, dt), 3.40 (1H, m), 3.26 (1H, m), 2.10 (1H, 
b), 1.95 (2H, bm), 1.82 (2H, b), +E+EP+EP-1.4 
(4H, m). 13C-NMR (100.4 MHz; drops CD3OD small amount of CDCl3) δ 171.6, 
104 
170.5, 163.9, 161.2, 139.1, 136.1, 135.7, 134.5, 132.6, 132.3, 82.8, 59.8, 58.8, 
57.4, 56.8, 55.8, 52.1, 4.12, 36.8, 36.6, 35.9, 31.8, 29.1, 28.7 MALDI (MNa+) 473 
(M-Boc+2H) 351Anal. Calcd. For C27H40N4O4 C, 62.77; H, 7.80; N, 10.84 found 
C, 62.51, H, 7.77, N, 10.62. 
3.6.5 Synthesis of trimer diamide (38): 
NH
NHBoc
OO
BocHN
HNCl
OO
Cl
NH2
NHBoc 38
32
NEt3
 
Figure 3.30 Synthesis of trimer diamide 38. 
Isophthalic acid (87.9 mg, 0.529 mmol) was stirred in 5 mL methylene 
chlRULGH2[DO\OFKORULGH/PPROZDVDGGHGXQGHUQLWURJHQ
pressure. Three drops of dry DMF caused the reaction to bubble vigorously, and 
the isophthalic acid to dissolve. After 1 h the reaction was evaporated under 
vacuum and dissolved in 5 mL methylene chloride again. 32 (288.9 mg, 1.348 
mmol) was added under nitrogen, and stirred overnight. The reaction stirred 
overnight at RT. Reaction was worked up with 3 mL brine and 10 mL EtOAc, 
then 1 N HCl until the aqueous extract was acidic. The organic layer was dried 
with Na2SO4 (anhydrous) and was crystallized with ethyl acetate and hexane. 
1H-NMR (400 MHz; CD3OD) δ +V+G+G
(1H, t), 6.65 (2H, d), 3.70 (2H, m), 3.38 (2H, m), 1.80 (4H, t), 1.67 (4H, m), 1.2-
1.4 (5H, m), 1.22 (18H, s) 13C-NMR (100.4 MHz; DMSOd6) δ 169.1, 158.8, 136.2, 
131.5, 129.5, 127.7, 80.2, 56.2, 55.1, 33.7, 33.4, 28.9, 26.4, 26.1 Anal. Calcd. for 
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C30H46N4O6 C, 64.49; H, 8.30; N, 10.03; O, 17.18 found C, 64.47; H, 8.45; N, 
9.91 IR: 3335.5(s), 3307.6(s), 2970.1(m), 2935.7(s), 2856.9(m), 1685.2(s), 
1647.5(s), 1582.4(w), 1530.2(s), 1449.9(w), 1365.5(m), 1322.9(m), 1283.1(m), 
1246.2(w), 1170.4(s), 1016.6(m)  
3.6.6 Synthesis of pentamer diamide (39) 
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Figure 3.31 Synthesis of pentamer diamide 39, 40. 
Isophthalic acid (163.1 mg, 0.9818 mmol) was stirred in 5 mL methylene 
FKORULGH2[DO\OFKORULGH/PPROZDVDGGHGXQGHUQLWURJHQSUHVVXUH
Four drops of dry DMF caused the reaction to bubble vigorously, and the 
isophthalic acid to dissolve. After 1 h the reaction was evaporated under vacuum 
and dissolved in 5 mL methylene chloride again. 35 (494.2 mg, 1.394 mmol) was 
dissolved with 10 mL CHCl3DQG/1(W3 and added under nitrogen to the 
isophthaloyl chloride, and stirred overnight. The reaction stirring overnight 
proceded under RT conditions. Reaction was worked up with 3 mL brine and 10 
mL EtOAc, then 1 N HCl until the aqueous extract was acidic. The organic layer 
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was dried with Na2SO4 (anhydrous) and was crystallized with ethyl acetate and 
hexane. The crystals of 39 could be deprotected by submission to a solution of 
30% TFA in methylene chloride giving the free amine 40 upon workup. 
1H-NMR (400 MHz; CD3OD) δ 8.12 (1H, s), 7.84 (2H, d), 7.58 (1H, t), 3.98 
(2H, m), 3.84 (2H, m), 1.98 (5H, dt), 1.81 (4H, m), 1.49 (4H, m), 1.40 (4H, b), 
1.28 (1H, m), 1.22 (2H, b); EA: Anal. Calcd. For C44H70N8O8 C, 62.98; H, 8.41; N, 
13.35; O, 15.25, found C, 62.63; H, 8.48; N, 13.07; IR (KBr Pellet): 3332.6(s), 
2932.9(s), 2856.1(m), 2605.1 (w), 2498.1(w), 1686.4(s), 1531.5(s), 1449.5(w), 
1366.2(w), 1319.3(m), 1280.1(w), 1174.0(m), 1040.6(w) 13C-NMR (50 MHz, 750 
/&'&O3/&'3OD) 167.7, 159.8, 157.0, 134.7, 130.4, 128.7, 79.4, 77.5, 
55.5, 55.1, 53.6, 53.3, 33.1, 33.0, 32.9, 32.3, 28.4, 25.2, 24.9, 18.9 
3.6.7 Synthesis of trimer (43) 
To a solution of 1,3-phenylene diisocyanate (0.1g, 0.63mmol) in CH2Cl2 (2 
mL) was added the 31 or 32 (0.268g, 1.25 mmol) stirred for 10 min A white gel 
was formed was washed with the ether. A white solid 42a / 42b was obtained in 
quantitative yield.  
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Figure 3.32 Synthesis of trimer 43  
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1-((1R,2R)-1-N-t-butyloxycarbonylamino-2-cyclohexyl)-3-[3-(3-(1R, 
2R)-1-N-t-butyloxycarbonylamino-2-cyclohexylureido) phenyl] urea [42a]: 
1H NMR (400MHz, CDCl3 + CD3OD at 40
oC): 7.23 (t, 1H, J=2.0 Hz), 
7.18(t, 1H, J=8.0 Hz), 7.06(dd, 2H, J=8.0, 2.0 Hz), 3.44(m, 2H), 3.20 (m, 2H), 2.0 
(m, 4H), 1.78 (m, 4H), 1.37 (s, 18H), 1.15 -1.34 (m, 8H) 13C NMR (100MHz, 
CDCl3 + CD3OD at 40
oC): 157.5, 157.0, 139.8, 129.0, 112.5, 108.8, 78.5, 54.3, 
53.0, 33.3, 26.8, 24.2. 
1-((1R,2R)-1-N-(2-amino-cyclohexyl)-2,2,2-trifluoroacetamide)-3-[3-(3-
(1R, 2R)-1-N-t-butyloxycarbonylamino-2-cyclohexylureido)phenyl] urea 
[42b]: 
1H NMR (400MHz, DMSOd6): 9.18 (d, 2H), 8.18 (bs, 2H), 7.15 (t, 1H, 
J=2.01Hz), 6.9-7.2 (m, 3H), 5.95 (d, 2H), 3.55-6.20 (m, 4H), 1.6-2.00 (m, 8H), 
1.2-1.7 (m, 8H). 13C NMR (50MHz, DMSOd6): 156.4, 155.7, 155.2, 140.7, 128.8, 
118.9, 110.8, 107.0, 53.8, 51.6, 32.6, 31.0, 24.5, 24.2 
1-((1R,2R)-1-amino-2-cyclohexyl)-3-[3-(3-(1R, 2R)-1-N-amino-2-
cyclohexyl ureido) phenyl] urea [42] : To a solution of 42a (87.0 mg, 0.15 
mmol) in chloroform: acetonitrile (3.0 mL, 1: 1) was added a solution of 
trifluoroacetic acid (25 µl, 0.33 mmol) at RT and stirred for 2h. Triethylamine (46 
µl, 0.33 mmol) was added to the reaction mixture to neutralize the TFA. It was 
then washed with the brine. The organic phase was dried (Na2SO4) and on 
evaporation a white solid was obtained (.12 mmol, 47mg, 79%). 
The compound 43 can also obtained by deprotecting 42b by its reaction 
with the Ba(OH)2 in quantitative yield. 
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1H NMR (400MHz, D2O + DCl): 7.29 (1H, t, J=2.4 Hz), 7.23 (t, 1H, J=8.4 
Hz), 6.96 (dd, 2H, J=8.4, 2.4 Hz), 3.56-366 (m, 2H), 2.95-3.08 (m, 2H), 1.68-2.08 
(m, 8H), 1.20-1.50 (m, 4H) 13C NMR (50 MHz, CD3OD): 158.2, 141.2, 130.3, 
114.4, 112.4, 56.7, 56.3, 34.9, 33.8, 26.6, 25.8. 
3.6.8 Synthesis of pentamer (44) 
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Figure 3.33 Synthesis of Pentamer 44, 45 
To the solution of dimer (34) in chloroform was added the 1,3-phenylene 
diisocyanate (41) in one lot. It was stirred for 10 min at RT. The solvent was 
removed and the residual thick gel was triturated with the dry ether to give the 
white solid in quantitative yield. 
1H NMR (400 MHz, DMSOd6): 9.29 (d, 2H, J=7.2 Hz), 8.14 (bs, 2H), 7.35 
(bs, 1H), 6.94-7.30 (m, 3H), 5.8-6.00 (m, 5.56), 3.20-3.45 (m, 8H), 1.75-1.96 (m 
8H), 1.56-1.68 (m, 8H), 1.10-1.40 (m, 16H). 13C NMR (50MHz, DMSOd6): 158.5, 
109 
156.0, 155.6, 154.9, 140.8, 128.6, 110.4, 106.7, 55.2, 52.7, 52.3, 51.5, 32.2, 
30.7, 24.2, 24.0. IR (KBr Pellet) cm-1: 3320.9(s), 2936.3(s), 2859.5(w), 
1702.4(m), 1649.6(m), 1562.3(s), 1492.9(w), 1317.8(w), 1317.8(w), 1206.0(s) 
3.7 Addendum 
3.7.1 Future work 
Work on this project will continue with the synthesis of more oligomers of 
29. Solution phase synthesis of these oligomers is being pursued using p-
nitrophenylchloroformate as an activating agent. The p-nitrophenylcarbamate 
intermediates are more stable than the isocyanate intermediate produced 
through the phosgene equivalents triphosgene and carbonyldiimidazole. If the 
stability of the p-nitrophenylcarbamate intermediates is high enough then they 
will be purified, and reacted pure with another free amine. Under these conditions 
purity of the products should be high. 
Oligomers will be studied under cosolvent conditions to determine if the 
materials will form helical structures. If it can be shown that the oligomers do 
form a helix, oligomers of varying length will be analyzed for helix formation. 
Coopertivity in the formation of the helix can be established through establishing 
a pattern of increasing ability to form a helix in solution.  
3.7.2 Membrane sensors 
Berrocal et al. tested the t-Boc-protected pentamer 39 for use as an 
ionophore in a liquid membrane sensor system. In this paradigm an ionophore 
acts as an embedded binding site that changes the electric potential across a 
membrane in the presence of the appropriate analyte above threshold 
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concentration. A first evaluation of these compounds as ionophores in anion-
selective electrodes, indicated some selectivity for sulfate among the tested 
hydrophilic anions. However, the response was much larger to more hydrophobic 
anions such as salicylate and thiocyanate. Hopefully, with a longer oligourea a 
more selective ionophore can be found. 
3.8 Conclusion 
Analysis of the oligomer 29 was encouraging for further development of 
the project. Modeling studies indicated the preference for β-structure from the RC 
plots but did not rule out the possibility of α-helix formation. A structure that can 
mimic the 2-state structure of proteins will be exciting to investigate, and may 
uncover what characteristics are unique to proteins. The preference for β-
structure was surprising. Comparisons with the structurally related cyclohexane 
β-amino acid led to the assumption that the materials would be helical. However, 
the presence of the β-state does not indicate that these materials will not bind to 
oxoanions as planed. The helix was the second largest energetic local minimum. 
In addition, oxoanions present multiple hydrogen bond acceptors and the 
modeled materials were stable and flexible in a Monte Carlo simulation in 
chloroform. Hopefully, cosolvents like TFE and HFIP that induce helicity in 
peptides will induce similar conformational changes in oligoureas. 
Binding was indicated by the NMR and CD analyses. Two separate 
binding constants were found in both the NMR and the CD analysis. Additional 
measurements of the binding with a less acidic anion are required to discount the 
possibility of acid base reactions influencing the results, and decrease error 
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measurements that might cast doubt upon the binding determination. Modeling 
studies suggest a mechanism for the increased CD absorbance upon formation 
of the 1: 1 complex of phosphate and the amide pentamer versus the complex of 
phosphate and the urea pentamer. We have found a mechanism of creating a 
foldamer that should exploit the additive powers of multiple weak hydrogen 
bonds, by creating a foldamer that could do what most de novo binding 
molecules do not do.  Strongly bind to an oxoanion. 
We synthesized two derivatives of 2-aminobenzimidazole that have an 
intramolecular hydrogen bond in a conjugated CN system. The synthesis 
methodology was simple if not high yielding. Products required only 1 or 2 steps 
to get from starting material to product. The compounds were not complex for 
either material, but showed interesting dynamics.  
The hydrogen bonds that were studied showed a complexity that defies 
the common perception that the intramolecular hydrogen bond is a simple tether 
linking the hydrogen bond donor and acceptor. Weak hydrogen bonds were 
found in guanidinobenzimidazole, that had an effect on the bond order of a 
conjugated system. In 1d,e another conjugated system was found with similar 
dynamics, but was stericly inhibited from forming an intramolecular hydrogen 
bond. The carboxamidine NH hydrogen atom was postulated to have very slow 
proton exchange due to the higher pKa of the carboxamidine moiety. This 
presented the opportunity to investigate hydrogen bonds in general. 
Two different alkylation patterns were analyzed for differences and 
similarities in the dynamic rate of exchange of alkyl and benzo protons in an 
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effort to determine the mechanism and effect of the intramolecular hydrogen 
bond for this conjugated system. A system was made for which the guanidine 
nitrogen atoms are either primary or secondary to limit the number of 
mechanisms that explain an apparent change in the bond order of these 
guanidinobenzimidazole derivatives.  
These studies provided a realistic vision of what to expect of 
intramolecular hydrogen bonds in the control of de novo designed conformations. 
It was found that, the six-centered intramolecular hydrogen bonds studied here 
were not necessarily stable enough to be used for the design of compounds 
needing conformational stability. In 1d,e the sigma bond at N1-C11 has hindered 
rotation from the steric barrier present in a totally planar conformation. Molecules 
1b,c  had no hindered rotation at C2-N10 except for the intramolecular hydrogen 
bond. It appeared that the more planar molecule had an increased effect upon 
the bond order of the conjugated system. 
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Appendices 
A.1 Crystal data and structure refinement for 1c, 1d, 33. 
 
Compound 1c 1d 33 
Empirical formula C14H21N5 C14H21N5 C20H33N4O4F3 
Formula weight 259.36 259.35 450.5 
Temperature (K) 173(1) 173(1) 145(1) 
Wavelength (Å) 0.71073 0.71073 0.71073 
Crystal system, 
space group 
Monoclinic, 
P 21/n 
Orthorhombic, 
P na21 
Triclinic, 
P 1 
Unit cell 
dimensions 
   
a(Å) 9.6450(10) 18.066(4) 4.9590(10) 
b(Å) 7.7760(10) 10.234(2) 11.218(2) 
c(Å) 18.874(3) 22.275(5) 11.410(2) 
α(o) 90 90 109.04(2) 
β(o) 95.559(10) 90 91.77(2) 
γ(o) 90 90 101.38(2) 
V(Å3) 1408.9(3) 4118.4(14) 585.09(19) 
Z, Calculated 
density (Mg/m3) 
4, 1.223 8, 1.121 1, 1.279 
Absorption 
coefficient (mm-1) 
0.077 0.075 0.105 
F(000) 560 1504 240 
Crystal size (mm) 0.28 x 0.24 x 0.12 0.44 x 0.30 x 0.30 0.60 x 0.10 x 0.03 
θ range for data 
collection 2.29 to 25.00 1.83 to 22.50 1.90 to 25.00 
Limiting indices 
-11K 
-9N 
-22O 
-19K 
-11N 
-23O 
-5K 
-13N 
-13O 
Reflections 
collected / unique 
9104 / 2479 
[R(int) = 0.0548] 
19888 / 5371 
[R(int) = 0.0762] 
4031 / 4031 
[R(int) = 0.0420] 
Completeness to θ = 25.00, 99.9% to θ = 22.50, 99.9% to θ = 25.00, 100% 
Absorption 
correction 
None None None 
Refinement 
method 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
Full-matrix least-
squares on F2 
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Data / restraints / 
parameters 
2479 / 48 / 177 5371 / 417 / 451 4031 / 267 / 281 
Goodness-of-fit on 
F2 
1.092 1.116 1.076 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0676, 
wR2 = 0.1381 
R1 = 0.0737, 
wR2 = 0.1638 
R1 = 0.0535, 
wR2 = 0.0865 
R indices (all data) R1 = 0.0870, 
wR2 = 0.1466 
R1 = 0.0908, 
wR2 = 0.1728 
R1 = 0.0729, 
wR2 = 0.0918 
Absolute structure 
parameter 
NA 0 -0.9(7) 
[meaningless !] 
Extinction 
coefficient 
0.007(3) NA 0.027(3) 
Largest diff. peak 
and hole (e Å-3) 
0.455 and -0.248 0.228 and -0.239 0.197 and -0.151 
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A.2 Crystal data and structure refinement for 1g. 
 
Compound  
Empirical formula C14 H21 N5 
Formula weight 259.36 
Temperature (K) 173(1) K 
Wavelength (Å) 0.71073 A 
Crystal system, 
space group 
"Monoclinic,  P 
21/c" 
Unit cell dimensions  
a(Å) 8.0810(3) 
b(Å) 21.1140(7) 
c(Å) 9.6270(3) 
α(o) 90 deg. 
β(o) 114.2021(14) 
γ(o) 90 deg. 
V(Å3) 1498.21(9) 
Z, Calculated 
density (Mg/m3) 
4,  1.150 
Absorption 
coefficient (mm-1) 
0.073 
F(000) 560 
Crystal size (mm) 0.26 x 0.25 x 0.20 
θ range for data 
collection 
1.93 to 27.49 deg. 
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Limiting indices 
-10<=h<=10 
-27<=k<=26 
 -12<=l<=12 
Reflections 
collected / unique 
11517 / 3457 
Completeness 100.00% 
Absorption 
correction 
Semi-empirical 
from equivalents 
Refinement method 
Full-matrix least-
squares on F^2 
Data / restraints / 
parameters 
3457 / 0 / 177 
Goodness-of-fit on 
F2 
1.032 
Final R indices 
[I>2sigma(I)] 
R1 = 0.0497 
wR2 = 0.1146 
R indices (all data) 
R1 = 0.0784 
wR2 = 0.1262 
Absolute structure 
parameter 
NA 
Extinction 
coefficient 
0.014(2) 
Largest diff. peak 
and hole (e Å-3) 
.294 and -.284 
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A.3  Crystal coordinates (X 10 4) for 33. 
               x             y             z           U(eq) 
 
C(1)         6083(5)       1003(2)       6220(2)       26(1) 
C(2)         4826(5)        508(2)       7231(2)       28(1) 
C(3)         4542(6)       -942(2)       6860(2)       40(1) 
C(4)         2849(6)      -1652(2)       5608(2)       45(1) 
C(5)         4000(6)      -1143(3)       4605(2)       41(1) 
C(6)         4283(5)        308(2)       4979(2)       35(1) 
C(1')        7568(5)       2966(2)      12615(2)       28(1) 
C(2')        6493(5)       3413(2)      11588(2)       28(1) 
C(3')        7482(5)       4869(2)      11938(2)       37(1) 
C(4')        6653(6)       5595(3)      13207(3)       42(1) 
C(5')        7653(6)       5123(3)      14206(2)       40(1) 
C(6')        6667(5)       3664(2)      13863(2)       35(1) 
N(7)         6426(4)       1207(2)       8435(2)       30(1) 
C(8)         5356(5)       1950(2)       9419(2)       26(1) 
N(9)         7276(4)       2717(2)      10384(2)       31(1) 
O(10)        2869(3)       1942(2)       9439(1)       31(1) 
N(11)        6472(4)       2389(2)       6587(2)       28(1) 
C(12)        8969(5)       3176(2)       7008(2)       27(1) 
O(13)        8782(3)       4408(2)       7527(2)       41(1) 
C(14)       11308(5)       5435(2)       8068(3)       37(1) 
O(15)       11122(3)       2807(2)       6907(2)       40(1) 
C(16)       12772(6)       5173(3)       9109(3)       47(1) 
C(17)       10166(6)       6639(3)       8576(4)       79(1) 
C(18)       13079(5)       5544(3)       7040(3)       43(1) 
N(19)        6677(4)       1563(2)      12253(2)       31(1) 
C(20)        8438(5)        796(2)      12030(2)       34(1) 
C(21)        7193(6)       -647(3)      11530(3)       43(1) 
O(22)       10943(4)       1153(2)      12165(2)       60(1) 
F(23)        8365(3)      -1267(2)      12134(2)       82(1) 
F(24)        4500(3)       -953(2)      11609(2)       55(1) 
F(25)        7582(4)      -1130(2)      10339(2)       84(1)         
________________________________________________________________________ 
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A.4  Crystal coordinates (X 10 4) for (1c) 
   x        y      z U(eq) 
     
N(1) 469(2) -509(2) 8024(1) 27(1) 
C(2) 434(2) 571(3) 7472(1) 27(1) 
N(3) 1671(2) 1437(3) 7459(1) 30(1) 
C(4) 3929(3) 1303(3) 8265(1) 36(1) 
C(5) 4522(3) 448(3) 8862(1) 38(1) 
C(6) 3777(3) -766(3) 9213(1) 36(1) 
C(7) 2408(3) -1158(3) 8982(1) 30(1) 
C(8) 1794(2) -322(3) 8380(1) 25(1) 
C(9) 2565(2) 893(3) 8030(1) 26(1) 
N(10) -580(2) 899(3) 6943(1) 31(1) 
C(11) -1773(3) 50(3) 6902(1) 29(1) 
N(12) -2709(2) 354(3) 6325(1) 34(1) 
N(13) -2101(2) -1072(3) 7404(1) 36(1) 
C(14) -2313(3) 1555(4) 5759(1) 41(1) 
C(15) -3965(3) -684(3) 6151(1) 36(1) 
C(16) -3677(3) -2583(3) 6033(1) 44(1) 
C(17) -5099(3) -340(4) 6627(2) 49(1) 
C(18) -1879(3) 571(4) 5121(2) 61(1) 
C(19) -3401(3) 2869(4) 5561(2) 52(1) 
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A.5  Crystal coordinates (X 10 4) for (1d) 
  
               x             y             z           U(eq) 
          
N(1A)        2078(2)       1736(4)        263(2)       43(1) 
C(2A)        2475(3)       2124(5)        761(2)       43(1) 
N(3A)        3183(2)       2354(4)        638(2)       42(1) 
C(4A)        3849(3)       2240(5)       -363(2)       47(1) 
C(5A)        3757(3)       1953(5)       -965(2)       54(1) 
C(6A)        3071(3)       1566(6)      -1188(3)       62(2) 
C(7A)        2454(3)       1461(6)       -814(2)       53(1) 
C(8A)        2559(3)       1732(5)       -220(2)       40(1) 
C(9A)        3239(3)       2131(4)         17(2)       38(1) 
N(10A)       2172(2)       2227(5)       1298(2)       61(1) 
C(11A)       1293(3)       1483(5)        252(2)       41(1) 
N(12A)       1154(2)        189(4)        343(2)       54(1) 
C(13A)        422(3)       -393(5)        327(3)       54(1) 
C(14A)        368(4)      -1298(8)       -214(4)      103(2) 
C(15A)        273(4)      -1114(7)        901(3)       96(2) 
N(16A)        801(2)       2348(4)        171(2)       49(1) 
C(17A)       1032(3)       3697(5)         42(3)       64(2) 
C(18A)        637(5)       4597(7)        452(4)      127(3) 
C(19A)        871(4)       4014(7)       -597(3)       80(2) 
N(1B)        4558(2)       1969(4)       2201(2)       41(1) 
C(2B)        4968(3)       2408(5)       1723(2)       43(1) 
N(3B)        5681(2)       2533(4)       1838(2)       45(1) 
C(4B)        6381(3)       2098(5)       2803(2)       47(1) 
C(5B)        6285(3)       1719(5)       3393(2)       51(1) 
C(6B)        5595(3)       1376(6)       3616(2)       56(1) 
C(7B)        4964(3)       1434(5)       3264(2)       49(1) 
C(8B)        5062(3)       1826(5)       2674(2)       42(1) 
C(9B)        5748(3)       2179(5)       2440(2)       41(1) 
N(10B)       4652(2)       2682(5)       1186(2)       57(1) 
C(11B)       3768(3)       1798(5)       2234(2)       40(1) 
N(12B)       3592(2)        521(4)       2252(2)       50(1) 
C(13B)       2853(3)         50(5)       2434(2)       56(1) 
C(14B)       2761(4)      -1350(7)       2255(4)      119(3) 
C(15B)       2761(3)        198(8)       3106(3)       84(2) 
N(16B)       3310(2)       2717(4)       2250(2)       42(1) 
C(17B)       3554(3)       4080(5)       2307(2)       49(1) 
C(18B)       3352(3)       4556(6)       2934(3)       70(2) 
C(19B)       3199(4)       4900(6)       1819(3)       88(2) 
O(1C)        2638(3)       3161(6)       5472(2)      111(2) 
O(2C)        1636(2)       1954(4)       5351(2)       92(2) 
C(1C)        1965(4)       3045(6)       5490(3)       76(2) 
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C(2C)        1437(4)       4046(6)       5658(4)      107(2) 
C(3C)        2080(5)        819(8)       5181(4)      116(3) 
C(4C)        2065(5)        642(9)       4575(3)      132(3) 
O(1D)        4770(3)      -1557(5)       2174(3)      121(2) 
O(2D)        5665(2)      -2798(4)       2532(2)       73(1) 
C(1D)        5414(4)      -1774(7)       2237(3)       81(2) 
C(2D)        6039(4)       -988(7)       2006(4)      106(2) 
C(3D)        5102(4)      -3619(8)       2782(4)      103(2) 
C(4D)        5460(4)      -4690(7)       3098(4)      112(3) 
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A.6  Crystal coordinates (X 10 4) for (1g)  
____________________________________________________________ 
  
                x             y             z          U(eq)        
____________________________________________________________ 
  
N(1)         5441(2)       2338(1)       5901(1)       29(1) 
C(2)         4685(2)       2594(1)       4476(2)       26(1) 
N(3)         4758(2)       2196(1)       3420(1)       27(1) 
C(4)         5935(2)       1074(1)       3696(2)       36(1) 
C(5)         6671(2)        594(1)       4740(2)       41(1) 
C(6)         7042(2)        677(1)       6273(2)       43(1) 
C(7)         6701(2)       1246(1)       6821(2)       38(1) 
C(8)         5966(2)       1727(1)       5772(2)       28(1) 
C(9)         5556(2)       1648(1)       4220(2)       27(1) 
N(10)        4008(2)       3191(1)       4330(1)       30(1) 
C(11)        2704(2)       3376(1)       3020(2)       29(1) 
N(12)        1948(2)       3017(1)       1764(1)       32(1) 
N(13)        2057(2)       3973(1)       2974(1)       35(1) 
C(14)        2595(2)       4375(1)       4325(2)       35(1) 
C(15)        2226(3)       5059(1)       3819(2)       51(1) 
C(16)        1637(2)       4180(1)       5325(2)       45(1) 
C(17)         447(2)       3192(1)        333(2)       35(1) 
C(18)        1062(2)       3616(1)       -647(2)       48(1) 
C(19)        -404(2)       2588(1)       -499(2)       49(1) 
____________________________________________________________ 
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A.7  NOSEY spectrum for (1d) 
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A.8 N-(1H-benzoimidazol-2-yl)- N’,N’-dimethyl-guanidine 1H NMR (300 MHz; 
acetone) 
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A.9 N-(1H-benzoimidazol-2-yl)- N’,N’-dimethyl-guanidine 13C NMR (75.4 MHz; 
MeOH) 
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A.10 2-Amino-1-benzimidazole- N,N’-diisopropylcarboxamidine 1H NMR (300 
MHz; CDCl3) 
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A.11 2-Amino-1-benzimidazole- N,N’-diisopropylcarboxamidine 13C NMR 
(75.4 MHz; CDCl3) 
p
p
m
2
0
4
0
6
0
8
0
1
0
0
1
2
0
1
4
0
1
6
0
1
8
0
c
r
y
 
o
f
 
d
i
i
s
o
p
r
o
p
y
l
 
g
b
 
t
h
a
t
 
h
a
v
e
 
b
e
e
n
 
d
e
s
o
l
v
a
t
e
d
 
o
f
 
e
t
h
y
l
 
a
c
e
t
a
t
e
P
u
l
s
e
 
S
e
q
u
e
n
c
e
:
 
s
2
p
u
l
 
S
o
l
v
e
n
t
:
 
C
D
C
l
3
 
A
m
b
i
e
n
t
 
t
e
m
p
e
r
a
t
u
r
e
F
i
l
e
:
 
p
w
1
3
7
d
e
a
c
e
t
a
t
e
_
C
I
N
O
V
A
-
5
0
0
 
 
"
c
a
r
i
b
e
"
P
U
L
S
E
 
S
E
Q
U
E
N
C
E
 
P
u
l
s
e
 
6
0
.
0
 
d
e
g
r
e
e
s
 
A
c
q
.
 
t
i
m
e
 
1
.
8
1
5
 
s
e
c
 
W
i
d
t
h
 
1
6
5
0
1
.
7
 
H
z
 
1
6
3
8
4
 
r
e
p
e
t
i
t
i
o
n
s
O
B
S
E
R
V
E
 
C
1
3
,
 
 
7
5
.
4
2
0
0
4
3
9
 
M
H
z
D
E
C
O
U
P
L
E
 
H
1
,
 
2
9
9
.
9
4
1
4
0
6
2
 
M
H
z
 
P
o
w
e
r
 
3
0
 
d
B
 
c
o
n
t
i
n
u
o
u
s
l
y
 
o
n
 
W
A
L
T
Z
-
1
6
 
m
o
d
u
l
a
t
e
d
S
i
n
g
l
e
 
p
r
e
c
i
s
i
o
n
 
d
a
t
a
D
A
T
A
 
P
R
O
C
E
S
S
I
N
G
 
L
i
n
e
 
b
r
o
a
d
e
n
i
n
g
 
1
.
0
 
H
z
F
T
 
s
i
z
e
 
6
5
5
3
6
T
o
t
a
l
 
t
i
m
e
 
8
 
h
r
,
 
1
8
 
m
i
n
,
 
3
6
 
s
e
c
120.578
122.641
116.718
77.232
77.652
76.811
24.071
 
130 
A.12 N-(1H-benzoimidazol-2-yl)- N’,N’-diisopropyl-guanidine 1H NMR (300 
MHz; CDCl3) 
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A.13 N-(1H-benzoimidazol-2-yl)- N’,N’-diisopropyl-guanidine 13C NMR (75.4 
MHz; Benzene) 
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A.14 2-Amino-1-benzimidazole- N’,N’-ditolylcarboxamidine 1H NMR (300 
MHz; CDCl3) 
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A.15 2-Amino-1-benzimidazole- N’,N’-ditolylcarboxamidine 13C NMR (75.4 
MHz; CDCl3) 
 
134 
A.16 N-(1H-benzoimidazol-2-yl)- N’,N” -diisopropyl-guanidine (1g) 13C NMR 
(100 MHz; CD3OD) 
 
135 
 
A.17 N-(1H-benzoimidazol-2-yl)- N’,N” -diisopropyl-guanidine (1g) 13C NMR 
(399.7 MHz; CD3OD) 
pw3-121 cry from EtOAc
1H  Axis = ppm  Scale = 161.45 Hz/cm X 80%
7.500 7.000 6.500 6.000 5.500 5.000 4.500 4.000 3.500 3.000 2.500 2.000 1.500 1.000 0.500 0.000  
136 
 
A.18 (33) 1H NMR (399.7 MHz; CDCl3) 
 
137 
A.19 (33) 13C NMR (100.5 MHz; CDCl3) 
 
 
138 
A.20 (39) 1H NMR (199.9 MHz; CDCl3) 
 
 
139 
A.21 (39) 13C NMR (50.3 MHz; DMSOd6) 
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